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Abstract

THE EFFECT OF MINOCYCLINE TREATMENT ON CELL PROLIFERATION AND
NEUROGENESIS IN THE HIPPOCAMPUS IN YOUNG AND AGED BRAINS
FOLLOWING TRAUMATIC BRAIN INJURY
Ashley L. Harvin
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University
Virginia Commonwealth University, 2012
Advisor: Dong Sun, MD, PhD., Department of Neurosurgery

Following traumatic brain injury, there is an enhanced cell proliferative and
neurogenic response in the young adult hippocampus, which may be associated with
innate cognitive recovery. However, in the aged brain, an increased level of
inflammatory cell responses was observed following injury concomitant to decreased
hippocampal neurogenesis and cognitive recovery in the aging population. This
suggests that excessive inflammation produced in the injured aging brain has a
detrimental effect on neurogenesis and cognitive function. In this study, we examined
the effect of anti-inflammatory treatment with minocycline on cell proliferation and
generation of new neurons in the dentate gyrus (DG) of the hippocampus in both young
and aged rats. Fisher 344 rats aged at 3 months and 20 months were subjected to a
moderate lateral fluid percussion injury (LFPI) or cortical impact injury (CCI).
Minocycline was administered intraperitoneally starting either at 30 minutes or 4 hours

x

post-injury, thereafter twice daily for 2 days. BrdU was injected at 2 days post-injury to
label injury-induced proliferating cells. To examine the effect of minocycline on cell
proliferation, generation of new neurons, and inflammatory cell response at the acute
stage post-injury, the rats were perfused 3 days post-injury. Brain sections were
immunostained for BrdU and early neuronal marker doublecortin (DCX). The results
show that short-term anti-inflammatory treatment with minocycline reduces the cell
proliferative response, presumably inflammatory cell responses, in young and aged rats
following LFPI and CCI injury, and enhances generation of new neurons in the
hippocampus in both young and aged rats following LFPI and in aged rats following CCI
injury. Therapies that enhance hippocampal neurogenesis may also have potential to
improve cognitive recovery following TBI.
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CHAPTER 1 - INTRODUCTION
Traumatic brain injury (TBI) is a serious disorder that can result in severe
behavioral and cognitive deficits. TBI is the leading cause of morbidity and mortality
after trauma and affects 3 out of every 1,000 Americans each year (Dutton and
McCunn, 2003). Post-traumatic cerebral inflammation, a secondary consequence of
TBI, is characterized by glial activation, leukocyte recruitment, and upregulation and
secretion of cytokines and chemokines (Ziebell and Morganti-Kossmann, 2010;
Cederberg and Siesjö, 2009). As the primary mediators of the inflammatory response to
CNS trauma, microglia play a vital role in the injured brain. While short-term microglial
activation is necessary to remove dying and damaged neurons and promote tissue
repair, chronic microglial activation is considered to be the most damaging response of
microglia to injury. Associations between damaged neurons and uncontrolled,
hyperactivated microglia can result in a self-propagating positive feed-forward loop that
leads to dysregulated and prolonged microglial activation and neuronal cell death, thus
driving the chronic progression of neurodegeneration.
The hippocampus is particularly vulnerable to insults (Dash et al., 2001), and
brain trauma is often characterized by learning, memory, and cognitive deficits (Witgen
et al., 2005). However, these deficits may spontaneously recover over time, suggesting
that there are innate repair and regeneration mechanisms that exist within the brain.
Previous studies from our laboratory and others have shown a significant increase in
cell proliferation in the hippocampal dentate gyrus (DG) in both injured juvenile and
adult rats after lateral fluid percussion injury and controlled cortical impact injury (Sun et
al., 2005; Rice et al., 2003; Chirumamilla et al., 2002; Dash et al., 2001). These injury1

induced newly proliferating cells are capable of differentiating into neurons and
integrating into the existing hippocampal circuitry, and thus may contribute to the
potential of innate cognitive recovery following TBI (Sun et al., 2007).
It is well known that aged patients recover to a lesser extent than younger
patients following TBI, but the mechanisms underlying this age-related disparity are not
fully understood (Hamm et al, 1992; Sun et al, 2005). Although new neurons are
continually generated throughout adulthood, multiple studies support that there is an
80% decline in neural stem cell proliferation and neurogenesis in the normal aged brain
(Seki and Arai, 1995; Olariu et al., 2007; Galvan and Jin, 2007; Kuhn et al., 1996; Rao
et al., 2006). Additional evidence indicates that in the aged brain, microglia when
activated exhibit an amplified inflammatory response (Cekic and Stein, 2010; Loane and
Byrnes, 2010). Our laboratory has observed that the injury-induced proliferative
response in the aged brain predominately generates microglial cells, and that newly
generated neurons fail to survive in this environment for an extended period of time
(unpublished data from the Sun laboratory). These findings led us to hypothesize that
enhanced levels of inflammation in the injured aged brain may contribute to reduced
neurogenesis and cognitive function, and that hippocampal neurogenesis in response to
injury can be restored by inhibiting the inflammatory response in the aged brain. To test
this hypothesis, we administered minocycline treatments to young adult and aged rats
to assess whether anti-inflammatory treatment could enhance hippocampal
neurogenesis after injury, particularly in the aged brain where microglia exhibit an
amplified response.

2

EPIDEMIOLOGY OF TBI
Traumatic brain injury (TBI) is a major global health concern and has affected
approximately 57 million people worldwide, resulting in approximately 10 million deaths
and hospitalizations each year. An estimated 1.5 million Americans sustain a TBI
annually, making it a leading cause of death and life-long disability in the United States
(McArthur et al., 2006). These injuries result in 1.1 million emergency department visits,
230,000 hospitalizations in which patients survive, and 80,000 people that experience
long-term disability (Thurman et al., 1999a). The CDC estimates that TBI is responsible
for one-third of all injury-related deaths, with approximately 50,000 Americans dying
each year following TBI (McArthur et al., 2006; Langlois et al., 2006). The populations at
the highest risk are adolescents, young adults, and the elderly. The incidence of TBI is
twice as high among males as it is among females, and adults aged 75 years and older
have the highest incidence of hospitalizations following TBI, mainly due to falls (Langlois
et al., 2006). Motor vehicle crashes, falls, and violence are the most common causes of
TBI (Thurman et al., 1999b; McArthur et al., 2006). Blasts are the leading cause of
military-associated TBI. Other major causes of TBI include sports and recreational
activities (Langlois et al., 2006).
Many people who survive TBI are faced with permanent neurologic problems and
disabilities including cognitive, behavioral, emotional, and sensory and motor
impairments (Hilton, 1994; Langlois et al., 2006). Even mild TBI can result in long-term
cognitive deficits that may interfere with an individual’s ability to carry out daily tasks or
return to work (Langlois et al., 2006). A person’s career and social and family
relationships may be profoundly and permanently altered following TBI. Cognitive
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functional deficits may cause the loss of communication skills and memory,
organizational and problem-solving skills, decreased attention span, and impaired
concentration (Thurman et al., 1999c). Emotional instability, personality changes,
agitation and aggressiveness, and impulsiveness may be a part of the injury-induced
behavioral sequelae typical of TBI (Hilton, 1994). In elderly persons, there is a 1.5 times
increased risk of depression and a 2.3 to 4.5 times increased risk of Alzheimer’s
disease depending on injury severity, making complications due to TBI especially
difficult for this age group (Langlois et al., 2006).

EXPERIMENTAL TBI
TBI can result in both focal and diffuse injury to brain tissue. The mechanisms of
injury include impact, rotational and inertial effects, and the combination of impact with
rotation. The type and severity of injury depends on the amount of energy transferred to
the head, the duration of injury, and the site of impact (McArthur et al., 2006). Focal
injuries are those that are caused by a blow to the head at the site of impact. It is
estimated that two-thirds of deaths from brain injury are due to focal injuries. Diffuse
injuries include those that result in severely dysfunctional and vegetative states as well
as mild concussive brain injuries. Severe diffuse injuries are the primary cause of
persistent neurological disability (Davis, 2000). The profile of injury typically seen in
human TBI represents a combination of focal and diffuse injury (McAllister, 2011).
In the laboratory setting, various experimental animal models are used to study
the effects of TBI (McArthur et al., 2006). In rodents, fluid percussion injury (FPI) is the
most widely used TBI model as it produces many of the pathologies observed in human
4

TBI, such as neuronal loss, gliosis, and perturbations in metabolic and ionic
homeostasis (Witgen et al., 2005; Dixon et al., 1987). With this model, injury levels can
be graded, where lower magnitudes of injury produce an injury similar to a concussion,
with brief neurological and physiological disruptions in the absence of remarkable
structural damage, and a higher magnitude of injury produces greater neurological
deficits, death, and widespread structural damage (Dixon et al., 1987). The controlled
cortical impact (CCI) model is often used to study focal brain injuries. The CCI model
uses a pneumatically driven impactor to induce focal TBI and causes significant cortical
tissue loss at the site of impact as well as hippocampal neuronal cell loss (Dixon et al.,
1991).

PATHOPHYSIOLOGY OF TBI
Although they are fundamentally different, focal and diffuse injuries share
common mechanisms in the pathophysiology of TBI (McAllister, 2011). Primary injury
results from immediate disruption of brain tissues following mechanical impact. Primary
injuries include focal injuries, diffuse injuries, penetrating injuries, and fractures (Davis,
2000). As a result, complex cellular and molecular cascades constitute the secondary
injury processes that are initiated and progress over a duration of hours to days after
the primary injury. A secondary injury cascade follows and causes the additional
pathophysiology in the brain, significantly contributing to poor prognosis following TBI
(Ray et al., 2002). These secondary responses includes changes in cerebral blood flow,
local and systemic inflammation, oxygen free radical generation, ischemia, edema,
increased intracranial pressure (ICP), apoptosis of neural cells, and excitotoxicity
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(Dutton and McCunn, 2003; Davis, 2000; McAllister, 2011). The inflammatory cascade
that is induced via the secondary response can be both beneficial or detrimental, as it is
a necessary part of healing yet harmful if exaggerated and uncontrolled (Dutton and
McCunn, 2003). Repair responses may also occur following TBI in an attempt to
promote functional recovery and regeneration of damaged neurons (Ray et al., 2002).

INFLAMMATORY RESPONSE TO TBI
Inflammation is a stereotypical reaction to tissue damage and has been
extensively reported in both experimental and clinical TBI. Cerebral inflammation in
response to trauma is a complex and multifactorial process characterized by glial
activation, leukocyte recruitment, and upregulation and secretion of cytokines and
chemokines (Ziebell and Morganti-Kossmann, 2010; Cederberg and Siesjö, 2009).
Post-traumatic inflammation had previously been thought to be deleterious for the
injured brain. However, recent studies suggest that inflammation has both beneficial
and detrimental roles, but the mechanisms underlying this dichotomy are largely
unknown (Ziebell and Morganti-Kossmann, 2010; Cederberg and Siesjö, 2009). In order
to achieve the benefits, the inflammatory response must be controlled and persist for a
defined period of time. However, sustained, excessive, or inappropriate inflammation is
the cause of numerous neuropathologies, including multiple sclerosis, Alzheimer’s
disease, and Parkinson’s disease (Ziebell and Morganti-Kossmann, 2010; Lucas et al.,
2006). Since the post-traumatic inflammatory response occurs after the initial insult and
partially parallels the development of secondary tissue damage, there has been much
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focus on the possibility of inhibiting particular components of inflammation to reduce
secondary damage (Cederberg and Siesjö, 2009).
The inflammatory cascade induced by brain trauma is mediated by the release of
pro- and anti-inflammatory cytokines, which are rapidly upregulated in response to
pathological or stressful situations yet barely detectable in healthy tissue (Ziebell and
Morganti-Kossmann, 2010; Lucas et al., 2006). The role of neuroinflammation in the
pathophysiology of TBI is controversial due to the dual role of cytokines in various
neuropathologies, as they can contribute to tissue repair as well as tissue destruction
(Morganti-Kossmann et al., 2001). Pro-inflammatory cytokines include interleukin (IL)-1#
and IL-1", tumor necrosis factor (TNF)-#, interferon-!, and IL-6, and are thought to
initiate inflammation via upregulation of adhesion molecules, release of chemokines,
activation of inflammatory cells, and production of nitric oxide (NO) and reactive oxygen
species (ROS) (Lucas et al., 2006). In contrast, anti-inflammatory cytokines, such as IL10, IL-4, IL-13, and transforming growth factor (TGF)-", function to downregulate and
counteract inflammatory and cytotoxic events (Cederberg and Siesjö, 2009).
Chemokines, or chemotactic factors, have the ability to attract inflammatory cells to the
injured site (Morganti-Kossmann et al., 2001).
Post-traumatic edema formation is a secondary consequence of TBI and results
in the breakdown of the blood-brain barrier (BBB) and subsequent cytotoxic events and
vascular leakage (Ray et al., 2002; Lenzlinger et al., 2001). The impairment of the BBB
in the acute post-traumatic period allows the entry of circulating neutrophils, monocytes,
and lymphocytes to the site of injury (Ziebell and Morganti-Kossmann, 2010; Lucas et
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al., 2006). The disruption of the BBB and subsequent accumulation of blood-borne
immune cells within the parenchyma has been observed in a variety of experimental TBI
models as well as in human TBI (Ziebell and Morganti-Kossmann, 2010; Lenzlinger et
al., 2001). These activated cells release an array of substances that are highly toxic to
cells including prostaglandins, free radicals, and pro-inflammatory cytokines, which then
induce the expression of chemokines and cell adhesion molecules and mobilize
immune and glial cells to the injured site (Ziebell and Morganti-Kossmann, 2010;
Cederberg and Siesjö, 2009). Eventually, production of anti-inflammatory mediators
suppresses humoral and cellular immune activation (Ziebell and Morganti-Kossmann,
2010). With time, repair mechanisms seal the sites of BBB leakage. However, a period
of time exists in which the endothelium in the damaged region remains permeable to
small molecules, which results in sustainment of an altered homeostasis of the brain
parenchyma and continued impairment of neuronal function. This prolonged
permeability allows for a window of opportunity in which drugs can reach the region of
injured brain tissue when they would otherwise be excluded from the CNS (Ziebell and
Morganti-Kossmann, 2010).
Neuronal dysfunction or death after injury or disease ultimately results in the loss
of CNS functions (Raghupathi, 2004). As the primary responders to CNS insults, glial
cells may play a vital role in the determination of clinical outcome (Sofroniew, 2005).
The activation of microglia is one of the central inflammatory responses to brain injury.
Microglia represent 10-20% of the total cell population in the adult CNS and function as
the primary mediators of the brain’s immune response to infection, injury, and disease
(Loane and Byrnes, 2010). Resident microglia in the CNS have an innate inflammatory
8

capacity and play several roles in the injured brain (Cederberg and Siesjö, 2009; Ziebell
and Morganti-Kossmann, 2010). Whether the microglial response to injury is beneficial
or detrimental is under debate, with strong evidence of a dual role and differential
activation (Loane and Byrnes, 2010; Hailer, 2008). However, it is important to note that
microglial responses vary depending on the severity of injury and injury model (Loane
and Byrnes, 2010).
The chief functions of microglia are to constantly survey their microenvironment
and detect any noxious agents or injurious processes. They clear toxic substances and
cellular debris after various kinds of tissue destruction by phagocytosis in order to
maintain cellular homeostasis in the CNS (Loane and Byrnes, 2010; Hailer, 2008). In
the CNS, resident microglia react to neuronal injury and BBB disruption caused by the
initial insult within minutes and can become chronically activated (Ramlackhansingh et
al., 2011). Chronic microglial activation persists weeks and months after the initial brain
injury (Loane and Byrnes, 2010). Microglia undergo morphological and behavioral
changes in response to injury. When activated, microglia contract their processes and
take on an ameboid morphology similar to that of peripheral macrophages, and then
proliferate and migrate toward the injured tissue (Loane and Byrnes, 2010; Hailer,
2008). With this transformation, microglia become indistinguishable from blood-borne
macrophages and function as antigen-presenting cells (Ramlackhansingh et al., 2011).
Activated microglia secrete cytokines and trophic factors that can exert protective or
harmful effects on neighboring cells (Lucas et al., 2006).
The view that microglia have a detrimental effect in the CNS following TBI is
supported by their release of vast numbers of cytotoxic chemicals and their association
9

with neuronal cell death (Loane and Byrnes, 2010; Hailer, 2008). Numerous studies
have reported that microglia release pro-inflammatory mediators, including proinflammatory cytokines, chemokines, NO, and superoxide free radicals that produce
ROS and reactive nitrogen species (RNS) after brain trauma. These neurotoxic
substances contribute to neuronal dysfunction and cell death following injury (Hailer,
2008). Although short-term microglial activation is not thought to be detrimental, chronic
microglial activation is considered to be the most damaging response of microglia to
injury. Associations between damaged neurons and uncontrolled, hyperactivated
microglia can result in a self-propagating positive feed-forward loop that leads to
dysregulated and prolonged microglial activation and neuronal cell death, thus driving
the chronic progression of neurodegeneration (Loane and Byrnes, 2010). In contrast,
short-term microglial activation may play a beneficial role in response to injury. Since
microglia phagocytose cellular debris and maintain cellular homeostasis, they function
to protect and preserve healthy tissue. Additionally, in response to injury microglia
release neuroprotective agents that promote neuronal survival or regeneration such as
anti-inflammatory cytokines and neurotrophic factors, including nerve growth factor
(NGF), TGF-", IL-10, and IL-1 receptor antagonist (IL-1ra) (Hailer, 2008).
Astrocytes, the predominant cell type in the human brain, may also influence
neuronal survival and functional outcome after TBI (Laird et al., 2008). In the uninjured
brain, astrocytes carry out several duties that are essential for neuronal function and
survival, including homeostatic maintenance of extracellular ionic environment and pH,
clearance of extracellular glutamate, production of pro- and anti-inflammatory cytokines
and chemokines, production of growth factors, and free radical release and scavenging
10

(Myer et al., 2006; Sofroniew, 2005). Astrocytes become “reactive” in response to all
CNS insults (Sofroniew, 2005). It is not known how reactive astrocytes affect the
progression of the injury response or overall outcome after TBI (Myer et al., 2006). As
with microglia, both beneficial and detrimental effects have been associated with
reactive astrocytes. Recent studies suggest that astrocytes may limit brain injury via
their role in regulation of homeostasis. However, other work indicates that reactive
astrocytes may contribute to increased neuroinflammation, the development of cerebral
edema, and increased ICP, thereby exacerbating secondary injury following TBI (Laird
et al., 2008). For example, a protective role may be provided by free radical scavenging
or neurotrophin release, while a harmful effect may be caused by free radical release or
pro-inflammatory cytokine production (Myer et al., 2006).
With edema formation and swelling, activation of resident immune cells, and
cerebral infiltration by immunocompetent cells, the post-traumatic brain shows the
hallmark signs of inflammation (Lenzlinger et al., 2001). The previous belief that
inflammation in TBI exacerbates cell death has been challenged by numerous reports
demonstrating that inhibition of the inflammatory response can actually increase cell
death and secondary tissue damage. It now appears that the most crucial element of
anti-inflammatory intervention is the timing of its administration. While pro-inflammatory
cytokines such as IL-1, IL-6, and TNF-# can all induce secondary tissue damage initially
after TBI, they may well do the opposite at later stages. Although no clear mechanism
for this has been presented, studies from non-CNS tissue damage indicate that the
initial inflammatory response induces anti-inflammatory and wound healing factors such
as IL-4, TGF-", and IL-10 at later stages (Cederberg and Siesjö, 2009).
11

TBI-INDUCED CELL PROLIFERATION AND NEUROGENESIS
The scientific community had previously thought that recovery from TBI was
severely limited due to the inability of the adult brain to replenish damaged neurons
(Ming and Song, 2005). However, several studies in the last decade indicate that the
mammalian CNS does have the potential to replace damaged neurons via neural
stem/progenitor cell (NSC/NPC) proliferation (Chirumamilla et al., 2002; Rice et al.,
2003). These stem and progenitor cells are present in both the developing mammalian
nervous system and in the adult nervous system (Song et al., 2002). NSC/NPCs
produce neurons and glial cells well into childhood and maintain cell replacement and
addition throughout adulthood, albeit to a lesser extent (Emery et al., 2005; Dash et al.,
2001; Jin et al., 2001). Glial progenitor cells are abundant and allow for continuous
production of glia throughout the brain (Carpentier and Palmer, 2009). However,
production of new neurons is restricted to two regions in the adult brain: the
subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus of the
hippocampus (Lois and Alvarez-Buylla, 1993). NSC/NPCs in the SVZ migrate down the
rostral migratory pathway and replace olfactory neurons in the olfactory bulb (Rice et al.,
2003). In the SGZ, these cells migrate into the hippocampal dentate gyrus (DG) and
differentiate into granular cell layer (GCL) neurons that are involved in networks that
modulate mood as well as short-term learning and memory (Carpentier and Palmer,
2009).
In the normal hippocampus, new neurons are continually generated and migrate
laterally from the hilus and SGZ into the GCL and eventually assume the nuclear and
cytoplasmic morphology of surrounding granule neurons (Emery et al., 2005; Cameron
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et al., 1993). Although many of these cells undergo apoptosis, those that survive can
integrate into the hippocampal circuitry by extending their axonal projections into the
CA3 region, the normal granule cell target area (Sun et al., 2007; Cameron and McKay,
2001). It has been reported that newly generated neurons in the SGZ and mature
granule neurons share the same neurophysiological characteristics, even when they are
born after an ischemic insult (van Praag et al., 2002; Song et al., 2002).
The hippocampus, a region responsible for memory and learning, is particularly
vulnerable to insults (Dash et al., 2001). Learning, memory, and cognitive deficits are
the hallmarks of brain trauma (Witgen et al., 2005). These deficits are observed early on
as a result of mild to moderate TBI, but spontaneously recover with time (Schmidt et al.,
1999). This limited capacity of the brain to restore itself naturally after injury suggests
that innate repair and regeneration mechanisms exist within the brain (Sun et al., 2005).
Aside from activation of microglia and astrocytes and the proliferation of cells at the site
of injury, the adult CNS has an additional response to injury that may have functional
significance and serve as an endogenous source for repair of the injured brain
(Chirumamilla et al., 2002; Rice et al., 2003).
Previous studies from our laboratory and others have shown a significant
increase in cell proliferation in the hippocampal DG in both injured juvenile and adult
rats after LFPI (Sun et al., 2005; Rice et al., 2003; Chirumamilla et al., 2002; Dash et al.,
2001). In particular, a study in our laboratory demonstrated that TBI generated a fourfold increase in cell proliferation in the SGZ in injured juvenile rats and a three-fold
increase in injured adult rats compared to age-matched shams, with TBI-induced
proliferation reaching a peak at 2 days post-injury before returning to basal levels by 14
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days post injury (Sun et al., 2005)(Figure 1-1, Sun, 2007). In the CCI model, increased
proliferation has also been observed in the DG that peaks at 3 days post-injury and
stays elevated at 60 days post-injury (Rice et al., 2003).
Several studies have been conducted to determine the composition of the
proliferative response in the neurogenic region of the DG in the juvenile and adult
brains. Results from our laboratory have shown that the percentage of newly generated
cells that differentiate into neurons in the SGZ was approximately two times higher in
juveniles than in adults at 7, 14, and 28 days post-injury. In contrast, significantly more
cells express astrocytic marker in adults compared to juveniles post-injury (Sun et al.,
2005). Our lab later examined the maturational fate of these newly generated cells 10
weeks after TBI and reported that the majority of the new cells that persisted in the DG
for this period of time differentiated into mature neurons (Figure 1-2). All of these cells
also exhibited positive immunostaining for calbindin, a protein present in all granule
neurons in the DG. Additionally, some of these surviving granule neurons have been
reported to extend axonal projections to the CA3 region as early as 14 days post-TBI
(Emery et al., 2005). Furthermore, these cells establish synaptic connections with
existing cells within the hippocampus, as determined with synaptophysin
immunoflourescent staining (Figure 1-3; Sun et al., 2007).
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Figure 1-1. Cell proliferation in the ipsilateral dentate gyrus in juvenile
and adult rats following TBI. Coronal sections taken from injured juvenile
(a) and adult (b) rats 2 days post- injury showing an elevated level of cell
proliferation as labeled with BrdU in the DG of injured juvenile and adult rats.
Arrows indicated BrdU-positive cells are clustered and concentrated in the
subgranular zone (SGZ) of the DG. (c) Quantification of BrdU-positive cells in
the SGZ. Graph shows that cell proliferation was significantly enhanced in
injured juvenile and adult rats at both 2 and 7 days post injury as compared to
age-matched sham controls (* p<0.05, ** p<0.01). The total number of
proliferating cells in injured juveniles was significantly higher than injured
adult rats at 2 days post injury (*p<0.05, n = 4/group). (d) Nissl stained
sections cross the hippocampal dentate gyrus with red box showing the
corresponding area in (a) and (b) (Sun et al., 2005). In addition, our lab has
demonstrated that new granule neurons generated following TBI can establish
the correct anatomical connections to the CA3 region (Fig. 1.3). To further
illustrate that these new neurons integrate into the existing neuronal circuitry,
using synaptic vesicle marker synaptophysin we have shown that newly
generated granule neurons form synapses with existing hippocampal neurons
(Fig. 1.4; Sun et al., 2007).
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Figure 1-2. Newly generated cells display markers for mature granule
cells. (a) Confocal micrograph showing newly generated BrdU+ cells within
the granule cell layer (green) at ten weeks post injury. In (b) the same cells
are labeled with the mature neuronal marker, NeuN (blue). (c) Granule
neurons retrograde incorporated with FG (red).

(d) Merged image of A, B

and C. Arrow points to one of the newly generated cells labeled with BrdU,
NeuN and FG while the arrow head points to a cell labeled with BrdU and
NeuN only. Scale bar: 30$m. (e-h) Confocal photomicrograph showing
newly generated cells express the granule cell marker, calbindin. The arrow
indicates a BrdU-labeled cell (green, E) which expressed calbindin (blue, f)
and was retrogradely incorporated with FG (red, G). (H) Merged image of E,
F, and G. Scale bar: 30$m.
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Figure 1-3. Newly generated granule neurons are retrogradely labeled
with FG and express synaptophysin. Confocal micrograph throughout the
z-axis showing (a) a newly generated BrdU+ cell (green) that is retrogradely
incorporated with FG (red) at ten weeks after its generation. (b) The same
BrdU-labeled cell is surrounded by a latticework of synaptophysin staining
(blue). (c) Merged image of (a) and (b). Scale bar: 30$m.
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FUNCTION OF HIPPOCAMPAL NEUROGENESIS
The function of newly generated neurons in the adult brain still remains unclear,
but recent evidence indicates that hippocampal neurogenesis has a critical functional
role in the normal adult brain, particularly in learning, long-term spatial memory, and
mood (Rao et al., 2006). It has been demonstrated that the mammalian hippocampus
regulates adult neurogenesis in an activity-dependent manner (Gould et al., 1999).
Additionally, increasing evidence has shown that neurogenesis in the adult
hippocampus may contribute to learning and memory functions (Sun et al., 2007). For
example, it has been demonstrated that living in an enriched environment induces a
robust increase in adult neurogenesis and enhanced survival of new neurons, and this
neurogenesis was paralleled by improved performance on a hippocampal-dependent
learning task. (Kempermann, 2002; van Praag, 1999). Evidence shows that physical
activity also increases adult hippocampal neurogenesis and is associated with improved
cognitive function and enhancement in spatial learning and long-term potentiation (van
Praag, 1999). Shors et al (2001) demonstrated that performance in a hippocampaldependent learning task was dependent on the replication of NSCs, indicating that adult
hippocampal neurogenesis has a role in learning and memory (Shors et al., 2001). It
appears that the association between neurogenesis in the adult hippocampus and
learning may be bidirectional, as one study showed that training in hippocampaldependent learning tasks enhanced the number of new granule cells and rescued new
granule cells from death (Kempermann, 2002; Gould et al., 2000). In contrast,
significant hippocampal cell loss after brain trauma has been associated with deficits in
memory function that are directly related to injury severity (Smith et al., 1991).
Additionally, diminished hippocampal neurogenesis, as observed following the
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administration of anti-mitotic drugs, irradiation or genetic ablation, was associated with
worse performance on hippocampus-dependent trace eyeblink conditioning (Shors et
al., 2001), contextual fear conditioning (Shors et al., 2002) and long term spatial
memory function tests (Rola et al., 2004; Jessberger et al., 2009). Collectively, these
studies support a strong association between normal adult hippocampal neurogenesis
and hippocampal function.
Despite the connection between neurogenesis and cognitive function, the
underlying mechanisms contributing to endogenous repair and regeneration following
TBI are not fully understood. In the injured brain, increased levels of proliferation of
granule cell precursors may be initiated by the death of mature hippocampal granule
neurons (Jin et al., 2001). Neuronal loss and dysfunction are thought to be the
underlying causes of behavior and cognitive deficits observed following TBI. Both
necrotic and apoptotic cell loss have been reported in the CA1, CA3, hilus, and dentate
gyrus regions of the hippocampus. (Dash et al., 2001). However, in both clinical and
experimental TBI studies, hippocampal-dependent learning and memory deficits often
diminish over time after injury (Sun et al., 2007). Together, these observations suggest
that innate mechanisms for repair and regeneration exist within the brain. The existence
of NSC/NPCs in the adult hippocampal DG throughout life and their enhanced levels of
proliferation in response to brain injury has led our lab to hypothesize that neurogenesis
may contribute to cognitive recovery after TBI. Furthermore, our laboratory has
observed that the time frame in which injury-induced newly generated cells differentiate
into mature granule neurons and integrate into existing hippocampal circuitry is
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coincident with the time course of spontaneous cognitive recovery as determined by
Morris Water Maze data following injury (Figure 1-4, Sun et al., 2007).

23

24

Figure 1-4. Cognitive deficits following TBI recover over time. Graph
comparing Morris water maze performance of injured rats to sham animals
during trials at days 11-15, 26-30 or days 56-60 following injury. Injured
animals displayed significant cognitive deficits, as characterized by a longer
latency, at 11-15 days post injury when compared to sham animals (*p<0.05).
These deficits persisted at 26-30 days (*p<0.05). At days 56-60, injured
animals showed cognitive recovery with a shorter latency which was not
significantly different to sham animals (Sun et al., 2007).
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TBI AND THE AGING BRAIN
Age is one of the most reliable and important predictors of morbidity and mortality
following TBI (Senathi-Raja et al., 2010). It is well known that juveniles exhibit greater
functional recovery than adult patients following TBI. Himanen et al. (2006) found that
higher age at injury (especially over 60 years of age) was a significant risk factor for
cognitive decline, while younger age at injury was associated with cognitive
improvement in a 30-year follow-up study (Himanen et al., 2006). After the age of 12,
there is a progressive increase in mortality and long-term morbidity after injury. For
example, elderly patients are twice as likely as younger patients to remain severely
disabled or vegetative after moderate TBI (Hamm et al., 1992). The age-associated
increases in morbidity and mortality following TBI can be observed in rodents. Hamm et
al. (1992) has shown that aged rats (20 months) were more than twice as likely to die
after fluid percussion TBI than young adult rats (3 months). It was also shown that when
young adult and aged rats are subjected to injury of the same severity, the aged
animals experience more severe impairment of both motor and cognitive function as
assessed by beam-walking and MWM performance. These greater cognitive and motor
deficits observed in aged rats are consistent with human clinical TBI (Hamm et al.,
1992).
The exact mechanisms underlying this age-related increase in vulnerability to TBI
are unknown. In the normal brain, there is a progressive decline in function with
increasing age (Lazarov et al., 2010). The normal aging hippocampus undergoes many
degenerative changes both morphologically and functionally that may contribute to
memory and learning deficits associated with older populations (Kuhn et al., 1996;
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Driscoll et al., 2006). Importantly, granule cells in the DG continue to be generated
throughout adulthood, but there is an 80% decline in NSC proliferation and
neurogenesis in the normal aged brain across several species (Seki and Arai, 1995;
Olariu et al., 2007; Galvan and Jin, 2007; Kuhn et al., 1996; Rao et al., 2006). However,
despite the reduced hippocampal neurogenesis associated with aging, the neurons that
are newly generated appear functionally equivalent to those in the young brain,
suggesting that neurogenesis in the aged brain is downregulated as opposed to
abberant (Lazarov et al., 2010).
Advancing age is accompanied by a decrease in the volume of the hippocampal
formation thought to be due to shrinking neuronal size, reduced neuronal and synaptic
density, decreased plasticity, and decreasing neurotransmitter levels (Senathi-Raja et
al., 2010; Driscoll et al., 2006; Brazel and Rao, 2004). Additionally, it has been observed
that aged rats with spatial memory impairments exhibit lower levels of dentate gyrus
neurogenesis than aged rats with preserved spatial memory (Rao et al., 2006). Thus,
reduced hippocampal neurogenesis appears to be related to both structural and
functional deficits of the hippocampus associated with aging (Driscoll et al., 2006;
Lazarov et al., 2010). Cellular changes in the aged brain such as increased oxidative
stress and damage to DNA and proteins may also contribute to cognitive decline (Brazel
and Rao, 2004).
It has been suggested that the brain may use the same mechanisms for
adaptation to aging that it does for recovery, and thus has a finite capacity for plasticity.
It appears that collective effects of TBI and aging may have a synergistic adverse effect
on cognitive outcome following injury, which may be in part due to the limited capacity of
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the aged brain to compensate during initial recovery (Senathi-Raja et al., 2010). The
aged brain demonstrates gene expression profiles representative of microglial activation
and neuroinflammation. Additionally, there is evidence that microglia in aged animals
exhibit an amplified inflammatory response when stimulated (Cekic and Stein, 2010;
Loane and Byrnes, 2010). Our laboratory conducted a study to measure the glial
response in injured young adult and aged brains at 28 days post-injury. The 20 month
old injured rat had slightly higher levels of GFAP, and significantly higher levels of ED1
and Iba1 than the 3 month old injured rat, suggesting that the aged animals have an
increased inflammatory response relative to the younger rats (Figure 1-5; unpublished
data from Sun, 2011). The neurological dysfunction observed in aged animals may be in
part due to this neuroinflammatory priming. We posit that enhanced microglial sensitivity
to immune activation does not resolve in the environment within the aged brain, which
may exacerbate secondary injury resulting in both a severe immune response as well
as immune factor release from damaged cells within the brain (Cekic and Stein, 2010).
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Figure 1-5. Level of glial response in the injured brain at 28 days postinjury. (a) and (b) In the ipsilateral GCL and hilus, the injured 20M old rat had
slightly higher percentage of GFAP expression than the 3M old rat, but not
statistically significant. (c) and (d) The injured 20M old had a significantly
higher percentage of ED1 expression in the ipsialteral GCL and hilus regions
than the 3M old counterpart. (e) and (f) The injured 20M old had significantly
higher expression of Iba1 in both the GCL and hilus regions than the injured
3M old (Sun et al., unpublished data).
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NEUROINFLAMMATION AND NEUROGENESIS
The inflammatory response to injury can produce both detrimental and beneficial
conditions for neurogenesis, as it imposes varying effects on neural progenitor cell
(NPC) proliferation, migration, differentiation, survival, and incorporation of newly born
neurons into the existing hippocampal circuitry (Sierra et al., 2010; Mathieu et al., 2010).
The profile of inflammatory mediators depends on the severity of inflammation, resulting
in varying consequences on neurogenesis. CNS inflammation ranges from mild acute to
uncontrolled chronic inflammation (Lucas et al., 2006; Whitney et al., 2009). During mild
acute inflammation, inflammatory mediators tend to promote neurogenesis, but
uncontrolled inflammation produces an environment that opposes neurogenesis (Sierra
et al., 2010; Pluchino et al., 2008). Additionally, the pro- and anti-neurogenic effects of
inflammation may also depend on the type and duration of microglial and/or astrocytic
activation (Das and Basu, 2008). An understanding of the potential effects of
inflammation on neurogenesis may potentially help identify therapeutic strategies for
treatment of neuronal injury (Whitney et al., 2009).
Independent studies have shown that microglial cell activation induced by an
LPS challenge in the brain is associated with a reduction in hippocampal neurogenesis
(Jakubs et al., 2008; Ekdahl, 2012). Additionally, hippocampal neurogenesis can be
restored by anti-inflammatory drug administration. These studies reported a negative
association between the number of activated microglia and the number of newly
generated neurons (Mathieu et al., 2010). Pro-inflammatory cytokines such as IL-1, IL6, and TNF-# are released by activated microglia and are thought to mediate the
relationship between microglia and neurogenesis. Microglial activation may also
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negatively regulate different steps of neurogenesis via release of prostaglandins
(Ekdahl, 2012).
TNF-# is primarily released by activated microglia and plays a role in several
neurodegenerative disorders. Based on the model and methods of injury, TNF-# can
display both pro- and anti-neurogenic effects. Lipopolysaccharide (LPS)- activated
microglia have been reported to inhibit neuronal differentiation via TNF-# expression.
When a TNF-# inhibitor was administered, neuronal differentiation was partially
restored, indicating that it has an anti-neurogenic effect when combined with LPSconditioned media. Furthermore, other data suggests that TNF-# released from
microglia may contribute to death of hippocampal NPCs after injury (Whitney et al.,
2009). Activated microglia may also suppress neurogenesis via production of IL-6. One
study reported that chronic production of IL-6 in a transgenic mouse model resulted in
dramatically reduced hippocampal neurogenesis via reduction of NPC proliferation,
survival, and differentiation (Whitney et al., 2009). Mathieu et al. studied the effects of
chronic expression of IL-1" and observed a 50% reduction in the percentage of injuryinduced proliferating cells that differentiated into neurons (Mathieu et al., 2010).
In contrast, the anti-inflammatory cascade is thought to promote neurogenesis,
as administration of anti-inflammatory cytokine TGF-" has been reported to support
neurogenesis (Ekdahl, 2012). However, in the aged brain, chronically activated
microglia induce a prolonged and amplified neuroinflammatory response (Cekic and
Stein, 2010). Ongoing inflammation in the CNS is associated with many
neurodegenerative disorders, and is known to play a role in neuronal death observed in
Alzheimer’s and Parkinson’s diseases (Ekdahl et al., 2003). Further, studies support
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that persistent inflammation may contribute to the memory loss in these disorders by
disrupting formation of new neurons (Das and Basu, 2008). The exaggerated
neuroinflammation in the aged brain results in reduced plasticity during recovery,
continued release of oxidative stressors, and enhanced production of inflammatory
cytokines such as TNF#, IL-1", and IL-6. In situations of chronic microglial activation,
these cytokines disrupt long-term potentiation, memory consolidation, neurite outgrowth,
and hippocampal neurogenesis (Cekic and Stein, 2010).
As discussed in the previous section, following TBI, there is a full range of
inflammatory cell responses including infiltration of macrophages and activation of
microglia and astrocytes accompanied with production of inflammatory cytokines. Our
laboratory has recently observed that following TBI, the aged brain retains cell
proliferative capacity; however, this injury-induced proliferative response predominantly
generates microglial cells. Moreover, new neurons generated in the aged brain failed to
survive for an extended period. These findings lead us to explore the hypotheses that
heightened levels of injury-induced inflammation in the aged brain may play a pivotal
role influencing neurogenesis and cognitive function, and that inhibition of this injuryinduced inflammatory response may restore hippocampal neurogenic response and
ultimately improve cognitive function of the injured aged animals.
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MINOCYCLINE AS A POTENTIAL THERAPY
Inflammation is a key component in the pathological environment following TBI,
and several components of this response have been identified as targets for therapeutic
intervention (Helmy et al., 2011). Potential inflammatory targets have included microglial
activation, leukocyte extravasation via adhesion molecules or matrix metalloproteinases
(MMPs), IL-1, TNF-#, and NO, among several others (Lucas et al., 2006). Minocycline,
a tetracycline antibiotic, has multiple targets and exhibits anti-inflammatory and
neuroprotective properties that have been demonstrated in many models of brain injury
(Hewlett and Corbett, 2006) . Minocycline reduces cytokine expression via inhibition of
microglial activation and inhibits MMP and the inducible form of nitric oxide synthase
(iNOS) actions (Yrjanheikki, 1999; Lucas et al., 2006). It also downregulates caspase-1,
which contributes to its anti-apoptotic properties. Minocycline has been used extensively
in humans for treatment of both chronic and acute conditions, including acne,
staphylococcal infections, and rheumatoid arthritis (Sanchez Mejia et al., 2001).
Minocycline is able to cross the BBB and inhibit microglial activation in
neurodegenerative disease models (Ekdahl et al., 2003). Most studies that have
reported neuroprotective effects of minocycline in rodents following brain injury have
used doses of 10-90 mg/kg administered intraperitoneally. Minocycline reaches peak
concentration in systemic circulation at 2.5 hours after intraperitoneal injection and has
a half-life of 3 hours in rats (Elewa et al., 2006). In a study examining the effects of LPSinduced microglia in a status epilepticus (SE) model, administration of minocycline
during a 5 week period after SE resulted in enhanced neurogenesis and a decrease in
the microglial population (Ekdahl et al., 2009), but minocycline did not affect
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neurogenesis in control animals (Ekdahl et al., 2003). Similarly, minocycline has been
shown to reduce functional impairment resulting from cerebral focal ischemia, and this
improvement is associated with decreased microglial activation and enhanced
hippocampal neurogenesis in addition to an improved neural environment after chronic
treatment (Liu et al., 2007). In another study, intraperitoneal administration of
minocycline 12 hours before or 30 minutes after TBI resulted in improved neurological
function compared to controls injected with saline (Sanchez Mejia et al., 2001).
Collectively, these studies suggest that modulation of microglia activation by
minocycline can enhance hippocampal neurogenesis. In this study, we will explore the
efficacy of anti-inflammatory treatment with minocycline as a potential therapy to restore
hippocampal neurogenesis and cognitive function following TBI. We administered
minocycline to both young adult and aged rats to begin to explore whether
inflammation-mediated reduction of hippocampal neurogenesis can be reversed by
inhibition of microglial activation, especially in the aged brain where microglia exhibit an
amplified response.
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CHAPTER 2 – METHODS AND MATERIALS
SUBJECTS
Male Fisher 344 rats aged at 3 months and 20 months (NIA) were used for this
study. The 3 month-old rats weighed approximately 300 grams and were housed in
pairs. The 20 month-old rats weighed approximately 450 grams and were housed
individually. Both groups were housed in a facility that maintained a temperature of 2022 degrees Celsius with a 12-hour light/dark cycle and with food and water available ad
libitum. Of the twenty-four young rats employed for this study, 16 were used to examine
minocycline treatment on injury-induced cell proliferation and generation of new neurons
at the early time post-injury. Of the seventeen aged rats employed for this study, 16
were used to study these effects. The remaining rats died immediately following injury
or within the first week following injury. The mortality rate for 3 month-old rats was 10%
following CCI injury and 43.8% following LFPI injury. The mortality rate for 20 month-old
rats was 0% following CCI injury and 30.8% following LFPI injury. All protocols and
animals used for this study complied with NIH guidelines and were approved by the
Institutional Animal Care and Use Committee at Virginia Commonwealth University.

SURGICAL PREPARATION AND PROCEDURE
Seven aged and seven young rats were subjected to a moderate lateral fluid
percussion injury (LFPI), and nine aged and nine young rats were subjected to a
moderate controlled cortical impact (CCI) injury following standard protocols. All tools
used for the surgical procedure were sterilized in an autoclave, and an aseptic
environment was prepared for the surgical procedures. The rats undergoing FPI were
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anesthetized with 5% isofluorane in a Plexiglas chamber, intubated, and ventilated with
2.5% isofluorane in a gas mixture (30% oxygen, 70% nitrogen). The rats undergoing
CCI injury were anesthetized with 5% isofluorane in a Plexiglas chamber, and were
ventilated through a nose cone with 2.5% isofluorane in a gas mixture (30% O2, 70%
N2) throughout the surgery. After shaving the scalp, the animal was secured in a
stereotaxic frame. To disinfect the site of incision, betadine was applied to the shaved
region of the head. Puralube ointment was placed in the eyes to prevent dryness during
the procedure. To expose the skull, an incision was made along the midline and the
surrounding connective tissue was pulled back and clamped with hemostats. A 4.9 mm
craniotomy was made on the left parietal bone midway between lambda and bregma
using a trephine and a Dremel drill with a small drill bit. The bone chip over the
craniotomy site was detached and any remaining bone fragments along the edges of
the craniotomy were carefully removed.

LATERAL FLUID PERCUSSION INJURY (L-FPI)
Once the craniotomy site was cleaned, a Luer lock fitting was placed over the
craniotomy and cemented in place with a dental acrylic mixture. When the acrylic had
dried, the fitting was filled with saline solution in order to ensure that it was completely
sealed and to provide a continuous medium though which the injury would be applied.
At this time, the rat was removed from isofluorane anesthesia until it regained
consciousness as assessed by demonstration of paw and tail reflexes. The fluid
percussion injury device (Figure 2-1) was calibrated by performing pressure
measurements every 30 seconds until the animal regained consciousness in order to
ensure that the device would produce an injury level within the target pressure range of
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1.77 ± 0.05 atm. The intubation tube was disconnected, the rat was removed from the
stereotaxic frame, and was then transferred and connected to the injury device via the
Luer lock fitting. A moderate fluid impulse of 1.77 ± 0.05 atm was applied. Once the
injury was administered, the animal was taken back to the surgery bench where the
fitting was removed from the skull. The rat was reconnected to ventilation without
isofluorane and placed in a supine position with gauze underneath the open incision.
Paw and tail reflexes and righting time were recorded during the recovery period in
order to assess the injury severity and verify that all animals received a comparable
injury. The rat’s righting time is the amount of time that passed from the point of injury
until the rat spontaneously returns to an upright position. Once this occurred, the
animals were again placed under anesthesia with 2.5% isofluorane and the incision was
sealed using 5-0 surgical suture with a sterile stainless steel suture needle. A triple
antibiotic ointment and 2% lidocaine hydrochloride jelly were applied to the sutured
region. A surgical drape was placed inside the cage and the rat was transferred back to
the cage, which was situated on a heating pad to aid the recovery process.
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Figure 2-1. Fluid percussion injury device. A photograph of the injury
device used to deliver lateral fluid percussion injury (LFPI) to young and aged
rats.
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CONTROLLED CORTICAL IMPACT (CCI) INJURY
Once the craniotomy site was cleaned, the rat was removed from isofluorane
anesthesia and transferred to the CCI injury device (Figure 2-2). To prepare the injury
device, the 3 mm steel impactor tip was carefully adjusted to a location perpendicular to
the surface of the brain just over the craniotomy so that the dura would not be pierced
upon delivery of the injury. Once the rat demonstrated a tail reflex, a moderate injury
corresponding to a 2.3 mm depression of the dura was delivered with a velocity of 4 m/s
and a dwell time of 0.05 seconds. After the injury was delivered, the incision was
sutured and the animal was allowed to recover following the same procedure as
described for the FPI injury. The time to regain paw and tail reflexes and righting time
were recorded as previously described, and once normal breathing was observed the
animal was transferred to its cage with a surgical drape placed inside and with the cage
over a heating pad. Sham animals underwent the same surgical procedure without
injury delivery.
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Figure 2-2. Controlled cortical impact injury device. A photograph of the injury
device used to deliver controlled cortical impact injury (CCI) to young and aged rats.
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MINOCYCLINE AND BRDU INJECTIONS
Minocycline is a tetracycline antibiotic that exhibits anti-inflammatory and antiapoptotic properties that have been demonstrated in many models of brain injury
(Hewlett and Corbett, 2006). Minocycline (Sigma) was administered intraperitoneally
(i.p.) to the 3 month-old and 20 month-old rats that underwent FPI and CCI injuries.
These animals were divided into two different minocycline treatment groups, group 1
and group 2 (Table 2-1). Of the seven aged rats subjected to FPI, four were assigned to
group 1 and three were assigned to group 2. Of the seven young rats subjected to FPI,
three were assigned to group 1 and four were assigned to group 2. Nine young and nine
aged rats received CCI injuries. In both age groups, three animals were vehicles, three
were assigned to group 1, and three were assigned to group 2.
Minocycline was dissolved in sterile saline at a 15 mg/ml concentration before
boiling point with neutral pH maintained. In treatment group 1, animals received a first
i.p. injection of minocycline at the dose of 45 mg/kg at 30 minutes post-TBI, followed by
a second dose of 45 mg/kg at 8 hours post-TBI. In treatment group 2, animals received
the first 45 mg/kg dose at 4 hours post-TBI, followed by a second dose at 8 hours postTBI. On the first and second days post-injury, both groups received minocycline i.p.
injections twice daily at a dose of 22.5 mg/kg with 12 hours in between. Vehicle
treatment animals received equal volume of sterile saline injection.
To label cell proliferation, 5-bromo-2’-deoxyuridine (BrdU, Sigma), a thymidine
analog that can be incorporated into the newly synthesized DNA of replicating cells, was
used. All animals received 4 doses of i.p. BrdU injection (50mg/kg, two hrs in between
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each injection) at two days post-injury. All animals in the study were sacrificed at 3
days following TBI (24 hrs after the last BrdU/minocycline injection).
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Table 2-1. Animal treatment groups in minocycline study. Table showing the
number of animals in each group in the minocycline study based on injury model,
age, and treatment group.
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LFPI

CCI

Young (3M)

Aged (20M)

Young (3M)

Aged (20M)

Sham

3

3

3

3

TBI+veh

4

4

3

3

Mino group 1 (30 min, 8 hr)

3

4

3

3

Mino group 2 (4 hr, 8 hr)

4

3

3

3
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TISSUE PROCESSING
Animals were sacrificed at 3 days post-injury. After deep anesthetization with
isofluorane until complete cessation of breathing, the rats were transcardially perfused
with 400 ml of 1x phosphate buffer solution (PBS) followed by 400 ml of 4%
paraformaldehyde in PBS. The skulls were then opened and the brains were removed
and post-fixed in 4% paraformaldehyde in PBS for a minimum of 48 hours at 4°C.
After 48 hours of post-fixation, the brains were placed in PBS. A Leica vibratome
was used to slice each brain into 60 µm thick coronal sections throughout the rostrocaudal extent of the brain. Four groups of 30 serial coronal sections were collected from
each brain, and the sliced tissue sections were collected into five 24-well plates filled
with PBS + 0.01% sodium azide and were stored in a refridgerator kept at 4°C until
needed for staining procedures.

IMMUNOHISTOCHEMISTRY
One set of 30 sections from each brain used in the study was stained for BrdU
immunohistochemistry to determine the number of newly proliferating cells in the DG
after injury. Another set of 30 sections from every brain used in the study was
processed for doublecortin (DCX), a microtubule-associated protein expressed by
immature neurons, to assess the number of newly generated neurons after injury.

BRDU IMMUNOSTAINING
Selected sections were first washed twice with PBS for 5 minutes and then
denatured in 50% formamide for 1 hour at 65°C. The sections were washed with 2x
saline sodium citrate (SSC) 2 times for 5 minutes, and then 2N HCl was placed on the
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sections for 30 minutes at 37°C. The sections were rinsed with PBS 2 times for 5
minutes, and quenched with 3% hydrogen peroxide for 1 hour on a shaker. The
sections were rinsed with PBS + 0.3% Triton100 for 10 minutes on the shaker before
adding a blocking buffer consisting of 5% normal horse serum in PBS + 0.3% Triton.
The sections were blocked overnight at 4°C on a shaker, and then incubated with the
primary antibody solution for 48 hours at 4°C on a shaker. The primary antibody solution
consisted of mouse anti-BrdU antibody (Dako, CA) at a 1:200 dilution in the blocking
buffer, and 300 µl was added to each well. Following 48 hour incubation, the sections
were brought back to room temperature and rinsed in PBS + 0.3% Triton100 for 10
minutes 3 times. The sections were then blocked in the blocking buffer solution for 3
hours at room temperature before they were incubated with the secondary antibody
solution at 4°C overnight on a shaker. The secondary antibody solution consisted of
biotinylated anti-mouse IgG (Jackson Laboratories, ME) at a 1:200 dilution in blocking
buffer, and 300 µl was added to each well. After overnight incubation, the sections were
brought back to room temperature and washed with 1x PBS for 10 minutes 3 times. The
avidin-biotin complex (ABC kit, Vector Laboratories) was prepared 30 minutes before
use at a concentration of 1:200 avidin and 1:200 biotin in 1x PBS. The sections were
incubated with ABC for 2 hours at room temperature on a shaker, and then washed with
1x PBS for 10 minutes 3 times. The liquid DAB solution was prepared using a Vector
DAB kit by adding 2 drops of phosphate buffer at a pH of 7.5, 4 drops of 3,3’Diaminobenzidine, and 2 drops of hydrogen peroxide to each 5 ml of nanopure water
required to incubate each section with 300 µl of DAB. The sections were incubated with
the DAB solution and the reaction was monitored under a microscope until the sections
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were adequately stained, and then quenched with 1x PBS to stop the reaction. The
sections were washed with 1x PBS for 5 minutes 3 times and stored in a refrigerator at
4°C. The sections were washed in distilled water and mounted to glass microscope
slides, with 6 sequential sections per slide.

DCX IMMUNOSTAINING
The sections were washed with 1x PBS for 5 minutes 2 times and then quenched
with 3% hydrogen peroxide 1 hour. They were then washed with PBS + 0.3% Triton100
for 5 minutes 3 times before incubation with the blocking buffer solution (5% normal
horse serum in 1x PBS + 0.3%Triton100) for 3 hours at room temperature on a shaker.
The sections were then incubated with a goat anti-rat DCX antibody (Santa Cruz, CA)
solution at a dilution of 1:1000 in blocking buffer for 48 hours at 4°C. After incubation,
the sections were washed with 1x PBS + 0.3% Triton100 for 10 minutes 3 times. Next,
they were blocked in blocking buffer for at least 3 hours at room temperature prior to
overnight incubation with biotinylated anti-goat IgG (Jackson Laboratories, ME) at a
dilution of 1:200 in blocking buffer at 4°C. The sections were then washed with 1x PBS
+ 0.3% Triton100 for 10 minutes 3 times and incubated with ABC for 2 hours at room
temperature. They were then washed with PBS and incubated with DAB at room
temperature, and the reaction was observed under a microscope. When adequately
stained, the sections were quenched with PBS and washed 3 times with PBS. They
were rinsed with distilled water and mounted on glass microscope slides, with 6
sequential sections per slide.
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COUNTERSTAINING PROCEDURE
Sections mounted on the glass slides were placed in distilled water and then
stained with 0.1% cresyl violet solution for 1 minute. They were washed in running tap
water 3 times, or until the water ran clear, and then placed back in distilled water. The
sections were then placed in ethanol in increasing concentrations (two 75% solutions,
one 95% solution) for approximately 1 minute each. They were placed in an acid alcohol
solution for approximately 30 seconds or until the counterstain color was appropriate,
and then dehydrated in 2 containers filled with 100% ethanol for 1 minute each. They
were placed in Citrisolv twice for 5 minutes each, and cover slipped with Permount.

STEREOLOGICAL QUANTIFICATION
The BrdU- and DCX-positive cells present in the DG were quantified using the
Olympic Image CAST program (Olympus, Denmark). Of the 30 coronal sections
obtained from each brain for each staining technique, 10 sections spanning the DG
(-2.56 mm to -5 mm of the bregma) were selected for examination using unbiased
stereological methods. Positively labeled cells in the ipsilateral hilus, subgranular zone
(SGZ), and granule cell layer (GCL) were counted in each of these sections. For the
BrdU quantification, the SGZ and GCL were counted together as the GCL. For the DCX
quantification, the SGZ and the hilus were counted together as the hilus. Under 4x
objective, the GCL and hilus were outlined and the cells within each region of interest
were counted under 40x objective focusing through the thickness of each section. In the
DCX stereological procedure, all neurons were categorized based on the vertical,
horizontal, or mixed orientation of their dendrites. The average thickness of the DG of
each brain was determined by measuring the depth of each section from one focal
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plane to another in 5 randomly selected locations in the DG, and then averaging the
thickness of all 10 sections to calculate the average thickness (t) of each brain. The
entire region of interest in each section was examined for stereological quantification
instead of random samples, so the average sampling fraction (asf) was equal to 1. The
dissector height (h) was set to 15 µm. Using these parameters, the total number of cells
in each DG was estimated as N=(%Q)(t/h)(1/asf)(1/ssf), where ssf was the sectionsampling fraction (ssf = 0.25), and %Q was the raw number of cells counted.

STATISTICAL ANALYSIS
Analysis of the righting times for animals following surgery was performed using
post-hoc student t-tests (only one-tailed t-tests were considered) to determine any
statistically significant differences within groups. Statistical analysis of cell proliferation
and neurogenesis data was performed using one-way ANOVA followed by post-hoc
LSD tests to determine differences in BrdU and DCX quantification data within
treatment groups. P-values less than 0.05 were considered statistically significant. No
two-way ANOVA analysis was performed.
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CHAPTER 3 - RESULTS
Numerous studies have suggested that inflammation plays a critical role in
modulating neurogenesis, and that the increased inflammatory response in the aged
brain may contribute to decreased neurogenesis and poorer cognitive recovery
following TBI. This study aimed to determine the effects of anti-inflammatory treatment
with minocycline on cell proliferation and neurogenesis in 3-month old young rats and
20-month old aged rats in the acute post-traumatic period. Two different minocycline
treatment groups were employed, with one group receiving a first minocycline dose at
30 minutes post-TBI (treatment group 1) and the other group receiving a first dose at 4
hours post-TBI (treatment group 2). Additionally, the effects of minocycline administered
in these two time courses in young and aged rats were examined in two most widely
used TBI models, namely, LFPI and CCI injury models. Micrographs showing the
location of the LFPI and CCI injuries relative to the hippocampus are shown in Figure 31. Fisher 344 rats were used for this study because it is the only strain that the aged
rats are available. A 3-month old Fisher 344 rat represents a fully mature, young adult,
and a 20-month old Fisher 344 rat represents a late middle-aged animal that is
comparable to a human approximately 50 years old (Hamm et al., 1992).
To assess whether anti-inflammation treatment with minocycline affects injuryinduced cell proliferation in the DG after LFPI and CCI, animals were injected with BrdU
four times 2 hours apart at 2 days post injury and sacrificed 3 days post injury. Ten
sections from each brain were stained for BrdU to label newly proliferating cells. These
cells are typically observed in the hilus or SGZ, which are the proliferating zones of the
hippocampal DG, and fewer newly proliferating cells are observed in the GCL. For this
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reason, BrdU-positive cells in the GCL and SGZ were taken together as the newly
proliferating cells in the GZ, and were counted separately from BrdU-positive cells in the
hilus. To assess whether anti-inflammation treatment with minocycline can enhance
hippocampal neurogenesis in the young and aged brains following LFPI and CCI injury,
ten sections from each brain of animals sacrificed 3 days post-injury were stained for
early neuronal marker DCX. In all animals, DCX-positive cells were primarily localized in
the SGZ of the DG, with some additional DCX-positive cells located in the GCL. In this
study, DCX-positive neurons in the GCL, SGZ, and hilus were all counted together as
newly generated neurons in the DG. Newly generated DCX-positive neurons were
classified according to three types of dendrite morphologies: vertically oriented
dendrites (Figure 3-2a), horizontally oriented dendrites (Figure 3-2b), and mixed
dendrites (Figure 3-2c). Neurons with horizontal and mixed dendrites were taken to be
newly generated cells after injury, while those with vertical dendrites were taken to be
neurons that were generated prior to injury. Expression of DCX in new neurons lasts
about 2 weeks.
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Figure 3-1. Location of LFPI and CCI injury. Micrographs taken from a) 3M sham
animal, b) 20M sham animal, c) 3M vehicle-treated animal following CCI injury, d)
20M vehicle-treated animal following CCI injury, e) 3M vehicle-treated animal
following LFPI injury, and f) 20M vehicle-treated animal following LFPI injury. These
images show the location of the injuries relative to the hippocampal region.
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Figure 3-2. Characterization of DCX+ newly generated neurons. Three
types of DCX+ cells are observed in the GCL: a) cell with vertically orientated
soma and dendrites, b) cells with horizontally orientated soma and dendrites,
c) cell with both horizontal and vertical dendrites (mixed dendrites). Confocal
micrograph shows BrdU/DCX double-labeled cells which are newly generated
DCX+ neurons at 2 days post-injury do not have vertical dendrites (Sun,
unpublished data).
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STUDY 1: EFFECT OF MINOCYCLINE TREATMENT IN LFPI MODEL
MORTALITY RATE AND RIGHTING TIME FOLLOWING LFPI
To assess the effect of minocycline on cell proliferation and neurogenesis after
LFPI a total of 14 young rats and 13 aged rats were used. The mortality rate in young
rats was 43.8% and in aged rats was 30.8%. These values are similar to those that
have been reported in other studies for young adult rats, but lower than those typically
reported for aged rats (Reid et al., 2010; Hamm et al., 1991). Due to the high sensitivity
of Fisher 344 rats to LFPI injury, the target injury level was slightly lowered in order to
increase survival rates during the study. The righting response, which is the time
required for an injured animal placed on its back to spontaneously return to an upright
position, was recorded immediately after injury as a measure of injury severity !Hamm,
2001). The mean ("SEM) righting time for young rats after LFPI was 12 "#2.08 minutes
for minocycline-treated animals and 10.13 ± 1.14 minutes for vehicle-treated animals.
Analysis of this data with a t-test indicated that there was no significant difference
between the righting times of the vehicles compared to the rats treated with
minocycline, indicating that a similar severity of injury was received by both groups (p =
0.95). The mean (±SEM) righting time for aged rats after LFPI was 8.89 ± 0.93 minutes
for minocycline-treated animals and 13.19 ± 2.17 minutes for vehicle-treated animals.
This difference was also not statistically significant, indicating that all animals received a
comparable injury (p = 0.07).
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THE EFFECT OF MINOCYCLINE ON CELL PROLIFERATION IN YOUNG ADULT
AND AGED RATS FOLLOWING LFPI
In 3 month-old sham animals, very few BrdU-positive cells were observed in the
DG, but the injured vehicle animals showed a greatly enhanced number of BrdUpositive cells (Figure 3-3). Animals treated with minocycline both 30 minutes and 4
hours post-TBI showed a reduction in the number of BrdU-positive cells in the GZ
following injury compared to vehicles. Stereological quantification of BrdU-positive
proliferating cells in the GZ and hilus showed that the vehicle-treated animals had
significantly more BrdU-positive cells compared to shams (p < 0.05 in GZ and hilus;
Figure 3-4). There were no significant differences in the number of BrdU-positive cells in
the GZ or hilus of animals treated with minocycline 30 minutes post-TBI or 4 hours postTBI compared to vehicle-treated animals. However, animals treated with minocycline in
either treatment group tended to show a reduced level of cell proliferation in the GZ and
hilus compared to vehicles (Figure 3-4). There was no significant difference in the
number of BrdU-positive cells observed in the GZ or hilus between treatment groups,
but those treated 4 hours post-TBI tended to show a slightly greater reduction of cell
proliferation following LFPI (Figure 3-4). This data suggests that administration of
minocycline in either treatment group tends to reduce the injury-induced cell proliferative
response in the DG in young rats after LFPI.
In the 20-month old rats, similar to young adult rats, very few BrdU-positive cells
were observed in the DG. Following injury, there was a marked increase in BrdUpositive cells in the vehicle-treated animals (Figure 3-3). Compared to injured vehicletreated animals, animals treated with minocycline starting at 30 minutes or 4 hours postTBI had a lower number of BrdU-positive cells. Stereological quantification of BrdU60

positive cells in the ipsilateral DG showed a significantly higher number of cell
proliferation in the GZ and hilus of vehicle-treated animals compared to shams (p < 0.05
in GZ and hilus, Figure 3-5). Following minocycline treatment, the number of BrdUpositive cells was decreased in the GZ in both treatment groups particularly in the 4 hr
treatment group. The number of BrdU-positive cells in the hilus was not significantly
affected (Figure 3-5). There was no significant difference in the number of newly
proliferating BrdU-positive cells in the GZ or hilus between the two treatment groups.
This data suggests that minocycline treatments administered 30 minutes or 4 hours
post-TBI tend to reduce cell proliferation after LFPI in aged rats. The decrease in cell
proliferation is more notable and trending toward significance in animals treated 4 hours
post-TBI.
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Figure 3-3. Newly generated cells in the ipsilateral DG at 3 days post-injury in
young and aged rats following LFPI. Micrographs taken from BrdU-stained coronal
sections in the ipsilateral DG from a) 3M sham animals, b) 3M injured vehicle-treated
animals, c) 20M sham animals, d) 20M injured vehicle-treated animals. a) In the 3month old sham, very few BrdU+ cells were observed in the DG. b) 3-month old
injured vehicle animals showed a greatly enhanced number of BrdU+ cells in the GZ
and hilus. c) Very few BrdU+ cells were observed in the DG of the 20-month old
sham animal, but the injured vehicle showed many more BrdU+ cells in the GZ and
hilus (d).
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Figure 3-4. Stereological quantification of cell proliferation in the
granular zone and hilus of young rats at 3 days post injury after LFPI. a)
In the ipsilateral GZ (GCL and SGZ), vehicle-treated injured animals had
significantly more BrdU+ cells compared to shams (*p<0.05). Animals treated
with minocycline 30 minutes and 4 hours post-TBI showed a reduction in the
number of BrdU+ cells compared to vehicle-treated animals, but did not reach
statistical significance. b) In the ipsilateral hilus, vehicle-treated animals
showed a significant enhancement in the number of BrdU+ cells compared to
shams (*p<0.05). Neither treatment group showed a significant difference in
the number of BrdU+ newly proliferating cells after injury compared to
vehicles, but the animals treated 4 hours post-TBI showed a reduction in the
injury-induced cell proliferative response. There was no significant difference
in the number of BrdU-positive cells between treatment groups among injured
animals in the GZ or hilus.
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Figure 3-5. Stereological quantification of cell proliferation in the
granular zone and hilus of aged rats at 3 days post-injury after LFPI. a) In
the ipsilateral GZ (GCL and SGZ), vehicle-treated animals showed
significantly enhanced cell proliferation compared to shams (*p<0.05).
Animals treated with minocycline 30 minutes post-TBI and 4 hours post-TBI
showed a reduced number of BrdU+ cells, which almost reached significance
in the 4-hour treatment group. b) In the ipsilateral hilus, vehicle-treated
animals had a significantly greater number of BrdU+ cells compared to shams
(*p<0.05). Animals treated with minocycline 30 minutes post-TBI did not have
a significantly different number of BrdU+ cells after injury compared to
vehicles, but animals treated 4 hours post-TBI showed a reduction in the
injury-induced proliferative response that almost reached significance.
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THE EFFECT OF MINOCYCLINE ON NEUROGENESIS IN YOUNG ADULT AND
AGED RATS FOLLOWING LFPI
To examine the effect of minocycline on neurogenesis, DCX staining was used to
quantify the number of newly generated neurons. New neurons are constantly
generated in the DG and new neurons express DCX for 2 weeks after generation. In
our study, animals were sacrificed at 3 days post-injury, and at this time injury-induced
new neurons were still at the early stage and lacking typical dendrites. DCX+ cells that
have vertical dendrites are likely new neurons born before injury, in contrast, DCX+ cells
that have not identifiable dendrites or with horizontal and mixed dendrites are likely new
neurons born after or around the time of TBI (Figure 3-6).
In 3 month-old rats, stereological quantification showed that the number of DCXpositive cells bearing horizontal or mixed dendrites was significantly increased in the
ipsilateral DG after LFPI in animals treated with minocycline at 30 minutes or 4 hours
post-TBI (p < 0.01; Figure 3-7a). There were no significant differences in the numbers
of DCX-positive cells in the DG between the two treatment groups or in the number of
DCX-positive cells in vehicle-treated animals compared to sham animals. A decrease in
the number of DCX-positive cells with vertical dendrites was observed in injured animals
with or without minocycline treatment but was not statistically significant (Figure 3-7a).
These data indicate that post-TBI administration of minocycline results in a significantly
increased number of injury-induced new neurons in the DG of young rats after LPFI in
both treatment time points.
In the 20 month-old rats, stereological quantification of DCX-positive cells in the
ipsilateral DG showed a significantly higher number of DCX-positive cells with horizontal
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and mixed dendrites in rats treated with minocycline starting at 30 minutes post-LFPI
compared to vehicles and shams (p < 0.01). Animals treated with minocycline 4 hours
post-TBI did not demonstrate an increased number of DCX-positive cells in the DG
following LFPI, and had significantly less DCX-positive cells with horizontal and mixed
dendrites than rats treated with minocycline 30 minutes post-TBI (p < 0.05, Figure 3-7b).
Quantification of the number of DCX+ cells with vertical dendrites revealed a significant
reduction in animals with minocycline treatment in both groups compared to vehicles or
sham animals (p < 0.01, Figure 3-7b).
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Figure 3-6. Newly generated DCX+ neurons in the DG at 3 days post-injury in
young and aged rats following LFPI. Micrographs taken from DCX-stained coronal
sections in the ipsilateral DG from LFPI injured animals at 3 or 20 months showing
many DCX+ cells in the 3 month brain compared to aged brain.

71

72

Figure 3-7. Quantitative analysis of the number of newly generated DCX+
neurons in 3 and 20 month old rats in the ipsilateral DG at 3 days
following LFPI. a) In the 3 month old animal, a significantly higher number of
DCX+ new neurons with horizontal or mixed dendrites was observed in
animals treated with minocycline either starting at 30 minutes or 4 hours postTBI compared to vehicles and shams (**p<0.01). No significant difference in
the number of DCX+ neurons was found between the two treatment groups.
A lower number of DCX+ cells with vertical dendrites were observed in all
injury groups compared to sham, but did not reach statistical significance. b)
In the 20 month old animals, a significantly higher number of DCX+ cells with
horizontal or mixed dendrites was observed in animals treated with
minocycline starting at 30 minutes post-TBI compared to vehicles and shams
(**p<0.01) and compared to animals treated with minocycline starting at 4
hours post-TBI (*p<0.05). Additionally, a reduced number of DCX+ cells with
vertical dendrites was observed in animals in both minocycline treated groups
compared to vehicles and shams (**p<0.01).
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STUDY 2: EFFECT OF MINOCYCLINE TREATMENT IN CCI MODEL
MORTALITY RATE AND RIGHTING TIME FOLLOWING CCI INJURY
To assess the effect of minocycline on cell proliferation and neurogenesis after
CCI, a total of twelve young rats and twelve aged rats were used. The mortality rate in
young rats was 10% and in aged rats was 0%. The righting response was recorded
immediately after injury as a measure of injury severity (Hamm, 2001). The mean
("SEM) righting time for young rats after CCI was 4.29 "#0.60 minutes for minocyclinetreated animals and 3.38 ± 0.71 minutes for vehicle-treated animals, which were not
statistically different (p = 0.59). The mean (±SEM) righting time for aged rats after CCI
was 5.63 ± 0.53 minutes for minocycline-treated animals and 4.25 ± 0.25 minutes for
vehicle-treated animals. This difference was also not statistically significant, indicating
that all animals received a similar severity of injury (p = 0.13).#

THE EFFECT OF MINOCYCLINE ON CELL PROLIFERATION IN YOUNG
ADULT AND AGED RATS FOLLOWING CCI INJURY
In the 3-month old rats, very few BrdU-positive cells were observed in the
ipsilateral DG of the sham animals. Following CCI injury, more BrdU-positive cells were
found in the vehicle-treated animals following CCI compared sham or injured with
minocycline treatment either starting at 30 minutes or 4 hours post-TBI (Figure 3-8).
Stereological quantification showed that the total number of BrdU+ cells was not
significantly different among sham, CCI-vehicle or CCI-minocycline groups. There were
no significant differences in the number of BrdU-positive cells in the ipsilateral GZ or
hilus between the two minocycline treatment groups (Figure 3-9).
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In the aged rats, very few BrdU-positive cells were observed in the ipsilateral DG
of the sham animals. Following injury a large number of BrdU-positive cells was
observed in the GZ and hilus in vehicle-treated animals compared to shams after CCI
injury (p < 0.05 in GZ, p < 0.01 in hilus; Figure 3-10 and Figure 3-11). There was no
significant difference in the number of BrdU-positive cells in the GZ and hilus of animals
treated with minocycline at 30 minutes post-TBI compared to vehicles. Similarly, while
the animals treated with minocycline 4 hours post-TBI showed a decreased number of
BrdU-positive cells in the GZ and hilus compared to vehicles, this difference did not
reach statistical significance (Figure 3-10 and Figure 3-11). There was no significant
difference in the number of BrdU+ cells in the GZ and the hilus of animals between
treatment groups. These data indicate that minocycline treatment tends to reduce the
injury-induced proliferative response in aged rats following CCI injury, but this reduction
in BrdU-positive cells in treated groups does not reach statistical significance.
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Figure 3-8. Newly generated cells in the DG at 3 days post-injury in young rats
following CCI injury. Micrographs taken from BrdU-stained coronal sections in the
ipsilateral DG from a) sham animals, b) injured vehicle-treated animals, c) animals
treated with minocycline 30 minutes post-TBI, and d) animals treated with
minocycline 4 hours post-TBI. (a) very few BrdU+ cells were observed in the sham.
(b) CCI injury resulted in a greatly enhanced number of BrdU+ cells in the DG, but
minocycline treatment 30 minutes post-TBI (c) and 4 hours post- TBI (d) caused a
reduction in the injury-induced cell proliferative response.
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Figure 3-9. Stereological quantification of cell proliferation in the
granular zone and hilus of young rats at 3 days post-injury after CCI. a)
In the ipsilateral GZ, a higher number of BrdU+ cells was observed in the
vehicle-treated animals compared to shams, but did not reach significance.
Animals treated with minocycline both 30 minutes and 4 hours post-TBI
showed a reduction in the injury-induced proliferative response, but this also
did not reach significance. b) In the ipsilateral hilus, vehicle-treated animals
had a greater number BrdU+ cells compared to shams, but were not
statistically significant. Animals in both minocycline treatment groups showed
a decreased number of BrdU+ cells compared to vehicles, but did not reach
statistical significance. There was no significant difference in the number of
BrdU+ cells between treatment groups.
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Figure 3-10. Newly generated cells in the DG at 3 days post-injury in aged rats
following CCI Injury. Micrographs taken from BrdU-stained coronal sections in the
ipsilateral DG from a) sham animals, b) injured vehicle-treated animals, c) animals
treated with minocycline 30 minutes post-TBI, and d) animals treated with
minocycline 4 hours post-TBI. (a) In the sham animal, there were very few BrdU+
cells in the ipsilateral DG. (b) Much more BrdU+ cells were observed in the DG of the
vehicle-treated animal after CCI injury. (c-d) Less BrdU+ cells were observed in
minocycline treated animals.
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Figure 3-11. Stereological quantification of cell proliferation in the granular
zone and hilus of aged rats at 3 days post-injury after CCI. (a) In the ipsilateral
GZ, injured animals with vehicle or minocycline at 30 min had a significantly higher
number of BrdU+ cells compared to shams (*p<0.05). Animals treated with
minocycline starting at 4 hours post-TBI showed a reduced number of BrdU+ cells
compared to vehicles, no statistical significance was reached compared to vehicles
after CCI. (b) In the ipsilateral hilus, vehicle-treated animals showed a significantly
enhanced number of BrdU+ cells compared to shams (**p<0.01). Animals treated
with minocycline 4 hours post-TBI had a lower number of newly proliferating BrdU+
cells compared to vehicles, but there were no significant differences in the number of
BrdU+ cells in either treatment group compared to vehicles. There were no significant
differences in the number of BrdU+ cells in the GZ or hilus between two treatment
groups.
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THE EFFECT OF MINOCYCLINE ON NEUROGENESIS IN YOUNG ADULT AND
AGED RATS FOLLOWING CCI INJURY
In the 3 month-old animals, following CCI injury, the number of DCX-positive
cells with horizontal and mixed dendrites was significantly higher in vehicle or
minocycline treated groups when compared to shams (p < 0.01, Figure 3-12a). The
number of DCX+ cells with vertical dendrites was slightly lower in the injured groups but
was not statistically significant.
In the aged rats, a higher number of DCX-positive cells with horizontal and mixed
dendrites was found in rats treated with minocycline at 30 minutes or 4 hours after CCI
injury compared to vehicles, but this enhanced neurogenesis was not significant in
either treatment group compared to vehicles (Figure 3-12b). However, injured animals
treated with minocycline had significantly more DCX+ cells compared to shams (p <
0.01 in CCI-mino at 30 min; p < 0.05 in CCI-mino at 4 hr). There was a significant
decrease in the number of DCX+ cells with vertical dendrites in the injured animals with
vehicles or minocycline treatment as compared to shams (p < 0.05). No significant
difference was found in the number of DCX+ cells with vertical dendrites among injured
groups.
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Figure 3-12. Quantitative analysis of the number of newly generated
neurons in the ipsilateral DG of young and aged rats at 3 days following
CCI. a) In the ipsilateral DG of young adult rats, animals treated with vehicle
or minocycline starting either at 30 minutes or 4 hours post-TBI showed a
significantly higher number of DCX+ cells compared to shams (**p<0.01). No
significant difference was found in the number of DCX+ cells with vertical
dendrites among all groups. b) In the ipsilated DG of aged rats, injured
animals treated with vehicle or minocycline had a higher number of DCX+
cells with horizontal and mixed dendrites compared to shams, and this
increase was statistically significant in animals treated 30 minutes post-TBI
(**p<0.01) and in animals treated 4 hours post-TBI (*p<0.05). A significantly
lower number of DCX+ cells with vertical dendrites was found in all injured
animals compared shams (*p<0.05), but not among injured groups.
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CHAPTER 4 – DISCUSSION
RESULTS SUMMARY
In this study, young adult and aged rats were subjected to mild to moderate LFPI
or CCI injury followed by a short-term minocycline treatment. The animals that received
minocycline treatment were randomly assigned to one of two treatment groups. Animals
in treatment group 1 received a first 45 mg/kg dose of minocycline at 30 minutes postTBI, then a second 45 mg/kg dose 8 hours post-TBI. Animals in treatment group 2
received a first 45 mg/kg minocycline dose at 4 hours post-TBI, followed by a second 45
mg/kg dose at 8 hours post-TBI. Both groups received two 22.5 mg/kg minocycline
treatments 12 hours apart on days 1 and 2 post-injury. The animals were sacrificed at 3
days post-injury to assess the effects of minocycline on cell proliferation and
neurogenesis in the DG of the hippocampus using BrdU and DCX staining.
Following LFPI, both 3 month and aged animals show increased cell proliferation
in the ipsilateral GZ and hilus regions compared to sham animals. Minocycline
treatment starting at 30 min or 4 hr post injury decreased the injury-induced cell
proliferation in both age groups, although this reduction did not reach statistical
significance likely due to the big standard errors within the group. Minocycline
treatment increased the number of newly generated neurons as characterized by
horizontal or mixed dendrites with DCX staining in both young and aged animals. This
treatment effect was significant when minocycline was given at both time points in
young adult animals and at 30 min post-injury in aged animals. Minocycline treatment
did not increase the number of DCX+ cells with vertical dendrites in both age groups,
but rather decreased the number of this type of cells in the aged groups.
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Following a mild to moderate CCI injury, all injured animals both young and aged
with minocycline treatment had a reduced number of BrdU+ cells in the ipsilateral GZ
and hilus region, but the reduction did not reach statistical significance similar to the
LFPI model. In this model, minocycline treatment slightly increased generation of new
neurons with DCX+ horizontal and mixed dendrites in the aged but not young rats.

TBI INDUCES AN INCREASED PROLIFERATIVE RESPONSE IN THE DG IN
BOTH YOUNG AND AGED RATS
It has been reported that NSC/NPCs are present in the adult mammalian brain
and are stimulated to rapidly proliferate in response to brain insults in what appears to
be an attempt of the brain to heal itself naturally after injury (Rice et al., 2003). In this
study, in the LFPI injury model, young and aged rats had increased cell proliferation in
response to injury in animals with vehicle treatment compared to shams. This response
is consistent with studies reported in our lab and others which have shown that injuryinduced cell proliferation in the adult brain peaks at 2 days post-injury in the DG (Sun et
al., 2005; Dash et al., 2001; Chirumamilla et al., 2002; Rice et al., 2003). Although
NSC/NPCs are present throughout adulthood, studies have confirmed a major reduction
in the number of these cells in the aged brain. This reduction was thought to contribute
to the declined cognitive function observed in the elderly population (Dash et al., 2001;
Artegiani and Calegari, 2012). In our current study, we found that the aged brain
showed a significantly increased number of proliferating cells in the DG following either
LFPI or CCI injury as compared to their age-matched shams. This suggests that the
aged brain retains proliferative capacity in the DG. Following CCI injury, in the young
animals the number of BrdU+ proliferation cells was not significantly higher than sham
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animals in the GZ and hilus, which is contrary to what has been reported before (Dast
et. al., 2002). This is likely due to the lower animal numbers included.

MINOCYCLINE REDUCES THE INJURY-INDUCED PROLIFERATIVE
RESPONSE
Studies from our lab have shown that in the hippocampus in adult animals, many
injury-induced proliferative cells are astrocytes and microglia (Chirumamilla et al.,
2002). Neuronal differentiation of newly generated cells was only observed in the
neurogenic region of the SGZ (Dash et al., 2001). In the aged brain, there is significantly
less neural progenitor proliferation, neuronal differentiation, and survival of new neurons
compared to the younger brain, and newly proliferating cells in the aged animals
differentiate predominantly into glial cells compared to young adult animals (Lee et al.,
2012).
Inflammation is a strong inhibitor of neurogenesis and is heightened in the aged
hippocampus. The concentration of activated microglia and secretion of proinflammatory cytokines in the brain increases with age. It has been reported that
activated microglia from aged mice exhibit increased secretion of pro-inflammatory
cytokines TNF-# and IL-6 compared to young mice, which is consistent with other
studies suggesting that the aged brain exhibits an amplified inflammatory response
when stimulated (Lee et al., 2012). Recently, our lab has observed that the aged brain
retains cell proliferative capacity following TBI, but this injury-induced proliferative
response predominantly generates microglial cells. In addition, we found that new
neurons generated in the aged brain failed to survive for an extended period of time. We
speculate that the amplified injury-induced inflammation in the aged brain may play a
89

critical role in modulating neurogenesis and cognitive function, and that inhibition of this
injury-induced inflammatory response may restore the hippocampal neurogenic
response and ultimately improve cognitive function of the injured aged animals.
In this study, minocycline, a widely used tetracycline antibiotic, was used to
inhibit the injury-induced inflammatory response. Minocycline has anti-inflammatory
effects inhibiting neutrophils, monocytes, and microglial cells (Elewa et al., 2006). In a
stroke model, minocycline was reported to decrease the microglial response in the DG,
preserve stroke-induced newly born hippocampal neurons, and reduce functional
impairment (Liu et al., 2007). Minocycline was also reported to protect neurons in an
acute toxin model of Parkinson’s disease where neuronal damage was predominantly
caused by inflammation. Administration of minocycline in an immune-inflammatory
encephalitis model resulted in decreased TNF-# release and enhanced secretion of
anti-inflammatory cytokine IL-10. Additionally, the anti-inflammatory effect of
minocycline have been observed in humans, as minocycline has been used to treat
rheumatoid arthritis and multiple sclerosis (Elewa et al., 2006). Collectively, these
studies suggest that minocycline has potential to modulate the inflammatory cascades
induced by TBI and as a result enhance neurogenesis following injury, especially in
aged patients where the inflammatory response is amplified.
In this study, both young and aged rats subjected to LFPI and CCI showed a
reduced injury-induced proliferative response after minocycline treatment starting at 30
minutes or 4 hours post-TBI. Since the proliferative response in young adult rats, and
especially aged rats, is predominately either microglia or astrocytes, these data are
consistent with other studies that have reported reduced microglial activation after
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minocycline treatment. While there were no statistically significant differences in the
number of BrdU-positive cells in the ipsilateral DG between minocycline treatment
groups in each age group and injury model, the reduction in the proliferative response to
injury appeared to be more marked in the animals treated with minocycline at 4 hours
post-TBI.

MINOCYCLINE ENHANCES NEUROGENESIS IN YOUNG AND AGED
ANIMALS FOLLOWING LFPI
The aged brain exhibits lower levels of neurogenesis than its younger
counterpart, which may contribute to learning and memory impairments associated with
aging. However, neurogenesis in the aged brain can be increased or even restored to
levels observed in the adult brain by several factors, including an enriched environment
and infusion of growth factors. Additionally, despite the age-associated decline in
hippocampal neurogenesis, studies suggest that age-related causes of reduced
neurogenesis do not affect the morphological properties of newly generated neurons,
which is important from a therapeutic perspective (Ahlenius et al., 2009).
The role of neuroinflammation in modulating neurogenesis is not fully
understood. It appears that microglia in the normal brain are necessary to preserve
neurogenesis and memory function, but microglia activated after brain insult impedes
neurogenesis. It has been reported that LPS-induced inflammation resulted in an 85%
reduction in the number of newly generated neurons during the inflammatory induction
in young adult rats. Additionally, systematic administration of LPS was found to increase
microglial activation and reduce neurogenesis, and this effect could be prevented by
anti-inflammatory treatment with nonsteroidal anti-inflammatory drug (NSAID)
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indomethacin. Microglia-mediated inflammation can regulate neurogenesis in two major
ways. They have the potential to be neurotoxic when they are removing dysfunctional or
damaged cells by producing reactive oxygen species and inflammatory cytokines
(Gemma et al., 2010). Microglia are the major producers of the key innate cytokines IL1" and TNF-# which are pro-inflammatory cytokines and capable of inhibiting NSCs
from differentiating into neurons (Lee et al., 2012). We speculated that inhibition of
microglia-mediated inflammation with minocycline would enhance neurogenesis,
especially in aged rats where microglial activation is amplified.
In this study, both young adult and aged rats subjected to LFPI and treated with
minocycline exhibited a reduction in the number of proliferating cells compared to the
injured vehicle group. Additionally, minocycline-treated young and aged rats showed an
increased number of new neurons as demonstrated by DCX+ cells bearing horizontal or
mixed dendrites. This is likely due to the inhibition of injury-induced microglia
proliferation and subsequent reduced inflammation. In our study, in young animals,
minocycline given beginning at 30 min or 4 hr after injury equally reduces cell
proliferation and increases DCX+ cells following LFPI injury but not CCI injury, whereas
in the aged animals minocycline treatment starting at 30 min post-injury has a more
positive effect in increasing the number of young DCX+ neurons. This suggests that
there are model and age-related differences in the injury-induced cell proliferative and
neurogenic responses. While inflammatory cell responses vary depending on injury
model (Loane and Byrnes, 2010), similarities and differences in microglial responses
and temporal cytokine profiles in the LFPI and CCI model have not been well
documented. These results also suggest varying pharmacokinetics of minocycline
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treatment by age or other factors that affect stem/progenitor cell function, neuronal
differentiation, or survival after injury (Gemma et al., 2010).
We speculated that aged animals would exhibit higher levels of neurogenesis
after injury with minocycline treatment due to the enhanced inflammation observed in
the aged brain relative to the younger brain. However, young adult animals also showed
a reduced cell proliferative response and enhanced neurogenesis following LFPI injury,
suggesting that minocycline may influence neurogenesis via another mechanism. In
addition to their anti-inflammatory and anti-oxidant properties, tetracyclines such as
minocycline have also been shown to have anti-tumor properties. Minocycline inhibits
cell proliferation by altering the cell cycle to arrest cells in the G0-G1 phase (Pourgholami
et al., 2012). It is possible that by suppressing cell proliferation in this way, minocycline
may drive early differentiation of cells into a neuronal phenotype in younger animals.
Furthermore, we found that both young and aged injured animals with or without
minocycline treatment have a lower number of DCX+ cells with vertical dendrites
compared to their age-matched shams following both LFPI and CCI injury. Most DCX+
neurons bearing vertical dendrites are new neurons born before injury and they are
vulnerable to TBI. This injury-induced reduction indicated the loss of these new
neurons due to the injury. Importantly, the decreased number of DCX+ cells with vertical
dendrites in injured animals was significant in aged animals but not young animals after
both LFPI and CCI injury. These results are consistent with other studies that have
reported increased apoptotic cell death in the hippocampus of aged rats compared to
young adult rats following brain injury (Itoh, 2012). Further, infarct development
progresses at an accelerated rate in aged rats compared to young rats, which is linked
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to apoptosis and early neuronal death as well as neuroinflammation. The rapid infarct
progression and cell death in the aged brain following TBi is at least in part due to free
radicals and oxidative stress, which also increases with age (Itoh, 2012; Popa-Wagner
et al., 2011). The increased vulnerability of brain tissue to TBI with age is consistent
with the neuronal loss observed in vehicle-treated aged animals.
Minocycline-treated animals were expected to have less neuronal loss than
vehicle animals due to the neuroprotective properties commonly attributed to
minocycline, yet this effect was not observed. Recent studies have shown that
minocycline has variable and even contradictory effects based on the species and
model of neurological disorder. For example, minocycline has demonstrated
neuroprotective effects in rodent models of ischemic injury and in global and focal
cerebral ischemia (Diguet, 2004). In contrast, other studies have reported that
minocycline had no effect on cell apoptosis in a mouse model of closed head injury
(Bye, 2006) and had deleterious effects in Parkinson’s, Huntington’s, and hypoxicischemic brain injury models (Diguet, 2004). Although the neuroprotective properties of
minocycline are likely associated with its anti-inflammatory properties and inhibition of
caspase pathways, further exploration of the mechanisms of minocycline in different
injury models would be useful in understanding its varying effects (Diguet, 2004).
Initially in this study, the effect of minocycline treatment on cell proliferation and
neurogenesis was to be observed in the LFPI model only, as previous studies in our
laboratory have been conducted using this model. However, Fisher 344 rats are highly
sensitive to LFPI, and have been reported to exhibit higher mortality rates, more
frequent seizure attacks, higher ICP, and more cell death than Sprague-Dawley rats of
94

the same age and subjected to the same injury level (Reid, 2010). Due to the high
mortality rates observed early in the study, we slightly lowered the target injury level to
increase survival rates following injury, especially in the aged rats that are particularly
susceptible to LFPI. This adjustment in LFPI injury severity is responsible for the low
mortality rates in the aged rats and the greater variation in LFPI injury results. The CCI
injury model was included in this study because Fisher 344 rats are better able to
tolerate the focal injury, as demonstrated by the almost complete lack of mortality
following injury in both young and aged rats. For this reason, the CCI injury was more
consistent among rats and produced more consistent results.

FUTURE OF MINOCYCLINE AS A POTENTIAL THERAPY
In this study, both young and aged rats showed a reduced injury-induced cell
proliferative response after treatment with minocycline in both LFPI and CCI injury
models. Furthermore, this reduction of injury-induced cell proliferation was concomitant
with enhanced hippocampal neurogenesis in both young and aged rats following injury.
While not all of these relationships showed statistical significance, the animals in the
groups that did not reach significance showed a high degree of variability in
stereological cell counts, which may have contributed to the lack of statistical
significance in these groups. However, these groups showed a trend towards
significance.
There were no statistically significant differences between minocycline treatment
groups in either cell proliferation or generation of new neurons in young or aged rats
after CCI or in young rats after LFPI, but aged rats treated with minocycline at 30
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minutes post-LFPI showed significantly enhanced neurogenesis compared to those
treated at 4 hours post-LFPI. The animals treated 4 hours post-TBI tended to show a
more marked reduction of the injury-induced cell proliferative response than the animals
treated 30 minutes post-TBI. The more effective minocycline treatment to enhance
neurogenesis differed among age and injury model groups. However, enhanced
neurogenesis was observed in all groups that showed a significant reduction of the
injury-induced proliferative response. These varying results may be due to differing
minocycline pharmacokinetics in rats of different ages or in response to different types
of injuries. Due to the big variations, addition of more animal numbers to each group
may reduce the observed variability in stereological counts and help identify the most
effective minocycline treatment for the groups in this study. Importantly, this study
identified the efficacy of minocycline treatment to reduce the number of injury-induced
proliferating cells. Further study to confirm this reduced cell population is indeed
microglia cells is needed. Overall, the data from this study shows that minocycline
treatment can enhance hippocampal neurogenesis in both LFPI and CCI injury models
concomitant to reduced injury-induced cell proliferation. These data strongly support
that microglia-mediated inflammation is detrimental to injury-induced neurogenesis, and
that inhibition of this inflammatory response may result in improved cognitive recovery in
patients. Future studies should also investigate the long-term effect of minocycline on
cell survival, neuronal differentiation, and inflammation.

96

LIST OF REFERENCES
1. Ahlenius, H., Visan, V., Kokaia, M., Lindvall, O., and Kokaia, Z. (2009). Neural
stem and progenitor cells retain their potential for proliferation and differentiation
into functional neurons despite lower number in aged brain. J. Neurosci. 29,
4408–4419.
2. Artegiani, B., and Calegari, F. (2012). Age-related cognitive decline: Can neural
stem cells help us? Aging (Albany NY).
3. Brazel, C. Y., and Rao, M. S. (2004). Aging and neuronal replacement. Ageing
Res. Rev. 3, 465–483.
4. Bye, N., Habgood, M.D., Callaway, J.K., Malakooti, N., Potter, A., Kossman, T.,
and Morganti-Kossmann M.C. (2007). Transient neuroprotection by minocycline
following traumatic brain injury is associated with attenuated microglial activation
but no changes in cell apoptosis or neutrophil infiltration. J. Exp Neurol. 204, 220233.
5. Cameron, H. A., Woolley, C. S., McEwen, B. S., and Gould, E. (1993).
Differentiation of newly born neurons and glia in the dentate gyrus of the adult
rat. Neuroscience 56, 337–344.
6. Cameron, H. A., and McKay, R. D. (2001). Adult neurogenesis produces a large
pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 435, 406–417.
7. Carpentier, P. A., and Palmer, T. D. (2009). Immune influence on adult neural
stem cell regulation and function. Neuron 64, 79–92.
8. Cederberg, D., and Siesjö, P. (2009). What has inflammation to do with traumatic
brain injury? Childs Nerv Syst 26, 221–226.
9. Cekic, M., and Stein, D. G. (2010). Traumatic brain injury and aging: is a
combination of progesterone and vitamin D hormone a simple solution to a
complex problem? Neurotherapeutics 7, 81–90.
10. Chirumamilla, S., Sun, D., Bullock, M. R., and Colello, R. J. (2002). Traumatic
Brain Injury Induced Cell Proliferation in the Adult Mammalian Central Nervous
System. J. Neurotrauma 19, 693–703.
11. Das, S., and Basu, A. (2008). Inflammation: a new candidate in modulating adult
neurogenesis. J. Neurosci. Res. 86, 1199–1208.
12. Dash, P. K., Mach, S. A., and Moore, A. N. (2001). Enhanced neurogenesis in
the rodent hippocampus following traumatic brain injury. J. Neurosci. Res. 63,
97

313–319.
13. Davis, A. E. (2000). Mechanisms of traumatic brain injury: biomechanical,
structural and cellular considerations. Crit Care Nurs Q 23, 1–13.
14. Diguet, E., Gross, C.E., Tison, F., Bezard, E. (2004). Rise and fall of minocycline
in neuroprotection: need to promote publication of negative results. J. Exp
Neurol. 189, 1-4.
15. Dixon, C. E., Lyeth, B. G., Povlishock, J. T., Findling, R. L., Hamm, R. J.,
Marmarou, A., Young, H. F., and Hayes, R. L. (1987). A fluid percussion model of
experimental brain injury in the rat. J. Neurosurg. 67, 110–119.
16. Driscoll, I., HOWARD, S., STONE, J., MONFILS, M., TOMANEK, B., BROOKS,
W., and SUTHERLAND, R. (2006). The aging hippocampus: A multi-level
analysis in the rat. Neuroscience 139, 1173–1185.
17. Dutton, R. P., and McCunn, M. (2003). Traumatic brain injury. Curr Opin Crit
Care 9, 503–509.
18. Edward Dixon, C., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., and Hayes, R.
L. (1991). A controlled cortical impact model of traumatic brain injury in the rat.
Journal of Neuroscience Methods 39, 253–262.
19. Ekdahl, C. T. (2012). Microglial activation - tuning and pruning adult
neurogenesis. Front Pharmacol 3, 41.
20. Ekdahl, C. T., Kokaia, Z., and Lindvall, O. (2009). Brain inflammation and adult
neurogenesis: the dual role of microglia. Neuroscience 158, 1021–1029.
21. Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003).
Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci.
U.S.A. 100, 13632–13637.
22. Elewa, H. F., Hilali, H., Hess, D. C., Machado, L. S., and Fagan, S. C. (2006).
Minocycline for short-term neuroprotection. Pharmacotherapy 26, 515–521.
23. Emery, D. L., Fulp, C. T., Saatman, K. E., Schütz, C., Neugebauer, E., and
McIntosh, T. K. (2005). Newly born granule cells in the dentate gyrus rapidly
extend axons into the hippocampal CA3 region following experimental brain
injury. J. Neurotrauma 22, 978–988.
24. Galvan, V., and Jin, K. (2007). Neurogenesis in the aging brain. Clin Interv Aging
2, 605–610.
25. Gemma, C., Bachstetter, A. D., and Bickford, P. C. (2010). Neuron-Microglia
98

Dialogue and Hippocampal Neurogenesis in the Aged Brain. Aging Dis 1, 232–
244.
26. Gould, E., Tanapat, P., Hastings, N., and Shors, T. (1999). Neurogenesis in
adulthood: a possible role in learning. Trends Cogn. Sci. (Regul. Ed.) 3, 186–
192.
27. Gould, E., Tanapat, P., Rydel, T., and Hastings, N. (2000). Regulation of
hippocampal neurogenesis in adulthood. Biol. Psychiatry 48, 715–720.
28. Hailer, N. P. (2008). Immunosuppression after traumatic or ischemic CNS
damage: it is neuroprotective and illuminates the role of microglial cells. Prog.
Neurobiol. 84, 211–233.
29. Hamm, R. J. (2001). Neurobehavioral Assessment of Outcome following
Traumatic Brain Injury in Rats: An Evaluation of Selected Measures. J.
Neurotrauma 18, 1207–1216.
30. Hamm, R. J., White-Gbadebo, D. M., Lyeth, B. G., Jenkins, L. W., and Hayes, R.
L. (1992). The effect of age on motor and cognitive deficits after traumatic brain
injury in rats. Neurosurgery 31, 1072–7; discussion 1078.
31. Hamm, R. J., Jenkins, L. W., Lyeth, B. G., White-Gbadebo, D. M., and Hayes, R.
L. (1991). The effect of age on outcome following traumatic brain injury in rats. J.
Neurosurg. 75, 916–921.
32. Helmy, A., De Simoni, M.-G., Guilfoyle, M. R., Carpenter, K. L. H., and
Hutchinson, P. J. (2011). Cytokines and innate inflammation in the pathogenesis
of human traumatic brain injury. Prog. Neurobiol. 95, 352–372.
33. Hewlett, K. A., and Corbett, D. (2006). Delayed minocycline treatment reduces
long-term functional deficits and histological injury in a rodent model of focal
ischemia. Neuroscience 141, 27–33.
34. Hilton, G. (1994). Behavioral and cognitive sequelae of head trauma. Orthop
Nurs 13, 25–32.
35. Himanen, L., Portin, R., Isoniemi, H., Helenius, H., Kurki, T., and Tenovuo, O.
(2006). Longitudinal cognitive changes in traumatic brain injury: a 30-year followup study. Neurology 66, 187–192.
36. Itoh, T., Imano, M., Nishida, S., Tsubaki, M., Mizuguchi, N., et al. (2012).
Increased apoptotic neuronal cell death and cogniive impairment at early phase
after traumatic brain injury in aged rats. Brain Struct Funct.
37. Jakubs, K., Bonde, S., Iosif, R. E., Ekdahl, C. T., Kokaia, Z., Kokaia, M., and
99

Lindvall, O. (2008). Inflammation regulates functional integration of neurons born
in adult brain. J. Neurosci. 28, 12477–12488.
38. Jessberger, S., Gage, F. H., Eisch, A. J., and Lagace, D. C. (2009). Making a
neuron: Cdk5 in embryonic and adult neurogenesis. Trends Neurosci. 32, 575–
582.
39. Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon, R. P., and
Greenberg, D. A. (2001). Neurogenesis in dentate subgranular zone and rostral
subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci.
U.S.A. 98, 4710–4715.
40. Kempermann, G. (2002). Why new neurons? Possible functions for adult
hippocampal neurogenesis. J. Neurosci. 22, 635–638.
41. Kuhn, H. G. H., Dickinson-Anson, H. H., and Gage, F. H. F. (1996).
Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of
neuronal progenitor proliferation. J. Neurosci. 16, 2027–2033.
42. Laird, M. D., Vender, J. R., and Dhandapani, K. M. (2008). Opposing roles for
reactive astrocytes following traumatic brain injury. Neurosignals 16, 154–164.
43. Langlois, J. A., Rutland-Brown, W., and Wald, M. M. (2006). The epidemiology
and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 21,
375–378.
44. Lazarov, O., Mattson, M. P., Peterson, D. A., Pimplikar, S. W., and van Praag, H.
(2010). When neurogenesis encounters aging and disease. Trends Neurosci. 33,
569–579.
45. Lee, S. W., Clemenson, G. D., and Gage, F. H. (2012). New neurons in an aged
brain. Behav. Brain Res. 227, 497–507.
46. Lenzlinger, P. M., Morganti-Kossmann, M. C., Laurer, H. L., and McIntosh, T. K.
(2001). The duality of the inflammatory response to traumatic brain injury. Mol.
Neurobiol. 24, 169–181.
47. Liu, Z., Fan, Y., Won, S. J., Neumann, M., Hu, D., Zhou, L., Weinstein, P. R., and
Liu, J. (2007). Chronic treatment with minocycline preserves adult new neurons
and reduces functional impairment after focal cerebral ischemia. Stroke 38, 146–
152.
48. Loane, D. J., and Byrnes, K. R. (2010). Role of microglia in neurotrauma.
Neurotherapeutics 7, 366–377.
49. Lois, C., and Alvarez-Buylla, A. (1993). Proliferating subventricular zone cells in
100

the adult mammalian forebrain can differentiate into neurons and glia. Proc. Natl.
Acad. Sci. U.S.A. 90, 2074–2077.
50. Lucas, S.-M., Rothwell, N. J., and Gibson, R. M. (2006). The role of inflammation
in CNS injury and disease. Br. J. Pharmacol. 147 Suppl 1, S232–40.
51. Mathieu, P., Battista, D., Depino, A., Roca, V., Graciarena, M., and Pitossi, F.
(2010). The more you have, the less you get: the functional role of inflammation
on neuronal differentiation of endogenous and transplanted neural stem cells in
the adult brain. J. Neurochem. 112, 1368–1385.
52. McAllister, T. W. (2011). Neurobiological consequences of traumatic brain injury.
Dialogues in Clinical Neuroscience 13, 287.
53. McArthur, D. L., Chute, D. J., and Villablanca, J. P. (2006). Moderate and Severe
Traumatic Brain Injury: Epidemiologic, Imaging and Neuropathologic
Perspectives. Brain Pathology 14, 185–194.
54. Ming, G.-L., and Song, H. (2005). Adult neurogenesis in the mammalian central
nervous system. Annu. Rev. Neurosci. 28, 223–250.
55. Morganti-Kossmann, M. C., Rancan, M., Otto, V. I., Stahel, P. F., and Kossmann,
T. (2001). Role of cerebral inflammation after traumatic brain injury: a revisited
concept. Shock 16, 165–177.
56. Myer, D. J., Gurkoff, G. G., Lee, S. M., Hovda, D. A., and Sofroniew, M. V.
(2006). Essential protective roles of reactive astrocytes in traumatic brain injury.
Brain 129, 2761–2772.
57. Olariu, A., Cleaver, K. M., and Cameron, H. A. (2007). Decreased neurogenesis
in aged rats results from loss of granule cell precursors without lengthening of the
cell cycle. J. Comp. Neurol. 501, 659–667.
58. Pluchino, S., Muzio, L., Imitola, J., Deleidi, M., Alfaro-Cervello, C., Salani, G.,
Porcheri, C., Brambilla, E., Cavasinni, F., Bergamaschi, A., et al. (2008).
Persistent inflammation alters the function of the endogenous brain stem cell
compartment. Brain 131, 2564–2578.
59. Popa-Wagner, A., Buga, A., Kokaia, Z. (2011). Perturbed cellular response to
brain injury during aging. Ageing Research Reviews 10, 71-79.
60. Pourgholami, M.H., Mekkawy, A.H., Badar, S.B., Morris, D.L. (2012). Minocycline
inhibits growth of epithelial ovarian cancer. Gynecologic Oncology 125, 433-440.
61. Raghupathi, R. (2004). Cell death mechanisms following traumatic brain injury.
Brain Pathol. 14, 215–222.
101

62. Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K.,
Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A.,
Gunanayagam, K., Gelosa, G., et al. (2011). Inflammation after trauma:
microglial activation and traumatic brain injury. Ann. Neurol. 70, 374–383.
63. Rao, M. S. M., Hattiangady, B. B., and Shetty, A. K. A. (2006). The window and
mechanisms of major age-related decline in the production of new neurons within
the dentate gyrus of the hippocampus. Aging Cell 5, 545–558.
64. Ray, S. K., Dixon, C. E., and Banik, N. L. (2002). Molecular mechanisms in the
pathogenesis of traumatic brain injury. Histology and Histopathology 17, 1137–
1152.
65. Reid, W. M., Rolfe, A., Register, D., Levasseur, J. E., Churn, S. B., and Sun, D.
(2010). Strain-related differences after experimental traumatic brain injury in rats.
J. Neurotrauma 27, 1243–1253.
66. Rice, A. C., Khaldi, A., Harvey, H. B., Salman, N. J., White, F., Fillmore, H., and
Bullock, M. R. (2003). Proliferation and neuronal differentiation of mitotically
active cells following traumatic brain injury. Exp. Neurol. 183, 406–417.
67. Rola, R., Otsuka, S., Obenaus, A., Nelson, G. A., Limoli, C. L., VandenBerg, S.
R., and Fike, J. R. (2004). Indicators of hippocampal neurogenesis are altered by
56Fe-particle irradiation in a dose-dependent manner. Radiat. Res. 162, 442–
446.
68. Sanchez Mejia, R. O., Ona, V. O., Li, M., and Friedlander, R. M. (2001).
Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation,
Tissue Damage, and Neurological Dysfunction. Neurosurgery 48, 1393.
69. Schmidt, R. H., SCHOLTEN, K. J., and MAUGHAN, P. H. (1999). Time Course
for Recovery of Water Maze Performance and Central Cholinergic Innervation
After Fluid Percussion Injury. J. Neurotrauma 16, 1139–1147.
70. Seki, T., and Arai, Y. (1995). Age-related production of new granule cells in the
adult dentate gyrus. Neuroreport 6, 2479–2482.
71. Senathi-Raja, D., Ponsford, J., and Schönberger, M. (2010). Impact of age on
long-term cognitive function after traumatic brain injury. Neuropsychology 24,
336–344.
72. Shors, T. J., Miesegaes, G., Beylin, A., Zhao, M., Rydel, T., and Gould, E.
(2001). Neurogenesis in the adult is involved in the formation of trace memories.
Nature 410, 372–376.
73. Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y., and Gould, E. (2002).
102

Neurogenesis may relate to some but not all types of hippocampal-dependent
learning. Hippocampus 12, 578–584.
74. Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G.,
Overstreet-Wadiche, L. S., Tsirka, S. E., and Maletic-Savatic, M. (2010).
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled
phagocytosis. Cell Stem Cell 7, 483–495.
75. Smith, D. H., Okiyama, K., Thomas, M. J., Claussen, B., and McIntosh, T. K.
(1991). Evaluation of memory dysfunction following experimental brain injury
using the Morris water maze. J. Neurotrauma 8, 259–269.
76. Sofroniew, M. V. (2005). Reactive astrocytes in neural repair and protection.
Neuroscientist 11, 400–407.
77. Song, H.-J., Stevens, C. F., and Gage, F. H. (2002). Neural stem cells from adult
hippocampus develop essential properties of functional CNS neurons. Nat.
Neurosci. 5, 438–445.
78. Sun, D., McGinn, M. J., Zhou, Z., Harvey, H. B., Bullock, M. R., and Colello, R. J.
(2007). Anatomical integration of newly generated dentate granule neurons
following traumatic brain injury in adult rats and its association to cognitive
recovery. Exp. Neurol. 204, 264–272.
79. Sun, D., Colello, R. J., Daugherty, W. P., Kwon, T. H., McGinn, M. J., Harvey, H.
B., and Bullock, M. R. (2005). Cell proliferation and neuronal differentiation in the
dentate gyrus in juvenile and adult rats following traumatic brain injury. J.
Neurotrauma 22, 95–105.
80. Thurman, D. J., Alverson, C., Dunn, K. A., Guerrero, J., and Sniezek, J. E.
(1999a). Traumatic brain injury in the United States: A public health perspective.
J Head Trauma Rehabil 14, 602–615.
81. Thurman, D. J., Alverson, C., Dunn, K. A., Guerrero, J., and Sniezek, J. E.
(1999b). Traumatic brain injury in the United States: A public health perspective.
J Head Trauma Rehabil 14, 602–615.
82. Thurman, D. J., Alverson, C., Dunn, K. A., Guerrero, J., and Sniezek, J. E.
(1999c). Traumatic brain injury in the United States: A public health perspective.
J Head Trauma Rehabil 14, 602–615.
83. van Praag, H. (1999). Running enhances neurogenesis, learning, and long-term
potentiation in mice. Proceedings of the National Academy of Sciences 96,
13427–13431.
84. van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., and Gage,
103

F. H. (2002). Functional neurogenesis in the adult hippocampus. Nature 415,
1030–1034.
85. Whitney, N. P., Eidem, T. M., Peng, H., Huang, Y., and Zheng, J. C. (2009).
Inflammation mediates varying effects in neurogenesis: relevance to the
pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem.
108, 1343–1359.
86. Witgen, B. M., Lifshitz, J., Smith, M. L., Schwarzbach, E., Liang, S.-L., Grady, M.
S., and Cohen, A. S. (2005). Regional hippocampal alteration associated with
cognitive deficit following experimental brain injury: a systems, network and
cellular evaluation. Neuroscience 133, 1–15.
87. Yrjanheikki, J. (1999). A tetracycline derivative, minocycline, reduces
inflammation and protects against focal cerebral ischemia with a wide therapeutic
window. Proceedings of the National Academy of Sciences 96, 13496–13500.
88. Ziebell, J. M., and Morganti-Kossmann, M. C. (2010). Involvement of pro- and
anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic
brain injury. Neurotherapeutics 7, 22–30.

104

VITA
Ashley Harvin was born in Poquoson, Virginia on January 12, 1988. She
graduated from Poquoson High School in 2006. After high school, she attended the
University of Virginia in Charlottesville, Virginia where she earned a Bachelor of Science
in Chemical Engineering in May of 2010. She attended Virginia Commonwealth
University in Richmond, Virginia in August of 2010 to complete a Master of Science in
Anatomy and Neurobiology. In August of 2012, she will be matriculating into the M.D.
program at the VCU School of Medicine as a member of the Class of 2016.

105

